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The human amniotic membrane (hAM) is a collagen-based extracellular matrix derived 
from the human placenta. It is a readily-available, inexpensive, and naturally 
biocompatible material. Despite its attractive biological and biochemical properties, the 
hAM has been restricted for some tissue engineering or regenerative medicine 
applications by its moderate mechanical properties and rapid biodegradation. In this 
work, the use of riboflavin, a water-soluble vitamin, is investigated to crosslink and 
strengthen the human amniotic membrane under UVA light. The effect of riboflavin-
UVA crosslinking on hAM properties were determined via infrared spectroscopy, 
uniaxial tensile testing, proteolytic degradation, permeability testing, SEM, and 
quantification of free (un-crosslinked) amine groups. Improved hAM mechanical 
properties must not come at the expense of reduced cellular proliferation and induction 
capabilities. In this study were assessed the viability, proliferation, immunophenotype, 
and multilineage differentiation ability of human adipose-derived stem cells seeded on 
riboflavin-UVA crosslinked membranes. Overall, hAM crosslinked with riboflavin-
UVA benefited from a stable 2.5-fold increase in mechanical properties and improved 
biodegradation, all while retaining their biocompatibility and abilities to support the 
cultivation and differentiation of adipose-derived stem cells. Together, these results 
suggest that riboflavin-UVA crosslinking is an effective strategy to enhance the hAM 
for potential cardiovascular and tendon tissue engineering applications. Additionally, 
porcine adipose-derived stem cells (pASCs) were identified as a reliable stem cell 
source thanks to their abundance, straightforward isolation, and broad differentiation 
xx 
abilities. Knowledge of the properties of pASCs is critical for the success of therapeutic 
studies in preclinical pig models. Finally, the construction of a simple mechanical 
testing apparatus using off-the-shelf materials and open-source software for a total cost 




Chapter 1: General Introduction 
 
The hAM is a collagen-based extracellular matrix derived from the human placenta. It is 
a readily-available, inexpensive, and naturally biocompatible material. Over the past 
decade, the development of tissue engineering and regenerative medicine, along with 
new decellularization protocols, has recast this simple biomaterial as a tunable matrix 
for cellularized tissue engineered constructs. Thanks to its anti-inflammatory properties 
and low immunogenicity, the hAM is now commonly used in a broad range of medical 
fields. New preparation techniques and composite scaffold strategies have also emerged 
as ways to tune the properties of the hAM. The current state of understanding about the 
human amniotic membrane (hAM) as a biomaterial is summarized in Chapter 2. 
 
In Chapter 2, the processing techniques available for the hAM are also examined, along 
with their effect on the mechanical properties, biodegradation, and cellular response of 
processed scaffolds. The latest in vitro applications, in vivo studies, clinical trials, and 
commercially-available products based on the hAM are reported, organized by medical 
field. The possible alterations to the hAM to tune its properties, either through 
composite materials incorporating hAM, chemical crosslinking, or innovative layering 
and tissue preparation strategies are also examined. Overall, Chapter 2 compiles the 
current literature about the myriad capabilities of the human amniotic membrane, 
providing a much-needed update on this biomaterial. 
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Despite its attractive biological and biochemical properties, the hAM has been restricted 
for some tissue engineering or regenerative medicine applications by its moderate 
mechanical properties and rapid biodegradation. To overcome these limitations, 
alterations to the hAM have been made to tune its properties, either through 
incorporating composite materials, chemical crosslinking, or innovative layering and 
tissue preparation strategies into the hAM.  
 
Chapter 3 describes the use of riboflavin, a water-soluble vitamin, to crosslink and 
strengthen the human amniotic membrane under UVA light. The effect of riboflavin-
UVA crosslinking on hAM properties were determined via infrared spectroscopy, 
uniaxial tensile testing, proteolytic degradation, permeability testing, SEM, and 
quantification of free (un-crosslinked) amine groups. Samples crosslinked with 
glutaraldehyde, a common and effective yet cytotoxic crosslinking agent, were used as 
controls. Improved hAM mechanical properties must not come at the expense of 
reduced cellular proliferation and induction capabilities. In Chapter 3 are also assessed 
the viability, proliferation, immunophenotype, and multilineage differentiation ability of 
human adipose-derived stem cells seeded on riboflavin-UVA crosslinked membranes. 
This work grew out from results obtained in my Master’s thesis, where the mechanical 
properties of the hAM were reported as insufficient for the development of small 
diameter tissue engineered blood vessels. Riboflavin-UVA crosslinking of the hAM 
was developed to improve the mechanical properties of the bare scaffold for potential 
cardiovascular and tendon tissue engineering applications. 
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Adipose-derived stem cells represent a reliable adult stem cell source thanks to their 
abundance, straightforward isolation, and broad differentiation abilities. Consequently, 
human adipose-derived stem cells (hASCs) have been used in vitro for several 
innovative cellular therapy and regenerative medicine applications. However, the 
translation of a novel technology from the lab to the clinic requires first to evaluate its 
safety, feasibility, and potential efficacy through preclinical studies in animals. The 
anatomy and physiology of pigs and humans are very similar, establishing pigs as an 
attractive and popular large animal model for preclinical studies. Knowledge of the 
properties of porcine adipose-derived stem cells (pASCs) used in preclinical studies is 
critical for their success. While hASCs have been extensively studied this past decade, 
only a handful of reports relate to pASCs. Chapter 4 summarizes the current findings 
about the isolation of pASCs, their culture, proliferation, and immunophenotype. The 
differentiation abilities of pASCs and their applications in porcine preclinical models 
are also be reported. 
 
Recently, open-source electronics have been used to build hardware/software systems 
that are yet not commercially available or otherwise too expensive. Among them, the 
popular Arduino microcontroller has already proven effective in controlling scientific 
hardware for research purposes while also serving as a practical platform for the 
training of students. The mechanical properties of soft materials are critically important 
for a wide range of applications ranging from packaging to biomedical purposes. 
Chapter 5 describes the construction of a simple mechanical testing apparatus using off-
the-shelf materials and open-source software for a total cost of less than $100. The 
4 
device consists of a wooden frame supporting a central loading apparatus attached via 
drawer slides. To perform a mechanical test, a sample was secured within two custom-
made 3D-printed clamps affixed to brackets on the base of the frame and the load cell. 
The extension force was applied by the user pulling on a rope, moving the central 
loading apparatus up (thereby stretching the sample) while recording the force 
(measured by a load cell) and the displacement (measured by an ultrasonic sensor). The 
load cell and ultrasonic sensor were linked to an Arduino microcontroller connected to a 
laptop through a USB port for data acquisition and analysis. 
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The human amniotic membrane (hAM) is a collagen-based extracellular matrix derived 
from the human placenta. It is a readily-available, inexpensive, and naturally 
biocompatible material. Over the past decade, the development of tissue engineering 
and regenerative medicine, along with new decellularization protocols, has recast this 
simple biomaterial as a tunable matrix for cellularized tissue engineered constructs. 
Thanks to its anti-inflammatory properties and low immunogenicity, the hAM is now 
commonly used in a broad range of medical fields. New preparation techniques and 
composite scaffold strategies have also emerged as ways to tune the properties of the 
hAM. The current state of understanding about the hAM as a biomaterial is summarized 
in this chapter. We examine the processing techniques available for the hAM, 
addressing their effect on the mechanical properties, biodegradation, and cellular 
response of processed scaffolds. The latest in vitro applications, in vivo studies, clinical 
trials, and commercially-available products based on the hAM are reported, organized 
by medical field. We also look at the possible alterations to the hAM to tune its 
properties, either through composite materials incorporating hAM, chemical 
crosslinking, or innovative layering and tissue preparation strategies. Overall, this 
chapter compiles the current literature about the myriad capabilities of the human 




Anatomy and Components 
The human amniotic membrane (hAM), also known as the amnion, is the innermost 
layer of the fetal membranes. It is loosely attached to the chorionic membrane, or 
chorion. Together, these fetal membranes form the amniotic sac, which contains the 
embryo and amniotic fluid during pregnancy. Both membranes are loosely connected 
via a spongy collagen layer, making them easy to peel and separate from each other.1 
 
The hAM is a translucent and avascular biomaterial with a thickness of 20 to 50µm.1,2 
As seen in Figure 01, the hAM consists of an epithelium monolayer in contact with the 
amniotic fluid, a basement membrane, a compact layer, a fibroblast layer, and then a 
spongy layer connected to the chorion.3 In a majority of tissue engineering applications, 
what is mentioned as the hAM actually refers to the basement membrane, decellularized 
and isolated from its surrounding layers to produce a thin and homogeneous 
biomaterial. Collagens type III, IV, and V are the major components of the basement 
membrane, providing structural integrity and mechanical strength to the tissue.4,5 Non 











Figure 1: Schematic representation of the structure of the human fetal 
membranes. The amnion is composed of 5 distinct layers: epithelium, basement 
membrane, compact layer, fibroblast layer, and spongy layer. 
 
Biological Properties 
The hAM possesses anti-microbial, anti-fibrosis, and anti-inflammatory properties.7,8 
When implanted into the human body it effortlessly adheres to the wound surface, 
reduces scars, decreases pain, promotes wound healing, and has a low risk of 
immunogenicity.9,10  
 
Another critical property of the hAM for tissue engineering applications is its ability to 
support cell attachment, proliferation, and differentiation.7 Various cell lines have been 
reported to adhere and proliferate on decellularized hAM. Figure 02 presents a specific 
example of the type of results numerous investigators have obtained, demonstrating that 
the culture of human mesenchymal stem cells on the hAM does not affect their 
immunophenotype or differentiation abilities.11 This unique set of biological and 
biochemical properties combined with its reduced cost and unlimited availability have 
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shaped the hAM into a biomaterial of choice for clinical and tissue engineering 
applications. 
 
Figure 2: Characterization of human mesenchymal stem cells derived from bone 
marrow (BM-dMSC) or from adipose tissue (ASCs) previously seeded on hAM 
scaffolds. A: Immunophenotype of the cells as determined by flow cytometric 
analysis. B: Chondrogenic (Alcian Blue staining), osteogenic (Alizarin Red 
staining), and adipogenic (Oil Red O staining) differentiation of the cells. The 
culture of both BM-dMSC and ASCs on hAM scaffolds did not affect their 
immunophenotype or differentiation abilities. Adapted from Roux et al.11 
 
Amniotic Membrane-Derived Cells 
The hAM has also been reported as a source of 2 populations of stem cells: human 
amniotic epithelial cells (hAECs) and human amniotic mesenchymal stromal cells 
(hAMSCs).12,13 hAECs are present on the epithelium monolayer facing the amniotic 
fluid. hAMSCs are part of the stromal layer found between the basement amniotic 
membrane and the loose spongy layer connected to the chorion, as depicted in Figure 
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01. Both of these cell lines can easily be obtained from the hAM after enzymatic 
digestion, typically with trypsin for hAECs, and collagenase for hAMSCs.14–16 
 
Cell isolation from the amniotic membrane has the advantages of being non-invasive 
and to provide large cell yields. hAECs and hAMSCs express transcription factors and 
cell surface markers associated with pluripotent stem cells and are able to differentiate 
into cell lineages from all three germ layers.14,17,18 Both of these cell lines can also be 
reprogrammed into induced pluripotent stem cells.19–21 Amniotic membrane-derived 
cells have been successfully used in several studies: bone tissue engineering,22 wound 
healing management,23 cartilage repair,24 and rheumatoid arthritis treatment.25 
 
Overall, hAECs and hAMSCs represent valuable sources of multipotent stem cells for 
tissue engineering and regenerative medicine applications. The possibility of obtaining 
these cells from the hAM adds even more value to this tissue, which is usually 
considered to be medical waste. The isolation, characterization, differentiation, and 
applications of amniotic membrane-derived cells have already been thoroughly 
reviewed.14,26–29 Consequently, the present chapter will only focus on the prospects 
offered by the human amniotic membrane. 
 
Historical Perspective 
The hAM was first used for skin reconstruction by Dr. Davis in 1910.30 Subsequently, 
the hAM was employed for a broad range of applications: surgical dressings, the 
treatment of burns and ulcers, the reconstruction of the oral cavity, bladder, and 
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vagina.31,32 In the 1940s the first ophthalmic applications of the hAM to treat 
conjunctival defects and chemical burns were reported.33–35 The initial interest for this 
biomaterial then faded away, most likely due to more stringent regulations regarding 
tissue transplantations, and the hAM almost disappeared from the literature for about 50 
years. 
 
The resurgence of the hAM happened in the 1990s when it was reported by Kim et al. 
as an effective scaffold for ocular surface reconstruction.36,37 New preparation, 
preservation, and storage techniques were also developed over the same time period, 
assisting the hAM to gain significance for ophthalmic and dermatologic applications 
without the worry of disease transmission from fresh unprocessed tissue. In 2001, 
processed hAM received approval from the United Stated Food and Drug 
Administration (FDA) for ocular surface reconstruction, increasing its use even further 
and triggering the development of several commercial hAM derived products.38 
Nowadays, the hAM has been widely adopted for burn wound dressing and ocular 
surface reconstruction. New clinical applications are also currently explored such as 
nerve wrapping,39–41 reconstruction of the oral cavity,42 flexor tendon repair,43 and the 
treatment of limbal stem cell deficiency.44  
 
The development of tissue engineering diversified the potential uses of the hAM as a 
scaffolding material from traditional fields such as ophthalmology and dermatology to 
new disciplines. Over the last two decades, novel hAM modifications have been 
incorporating cells and utilizing the hAM as a scaffold to recreate complex 3D 
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structures as opposed to last century uses as an acellular dressing.37 An ideal scaffold 
for tissue engineering applications is non-immunogenic and supports the attachment and 
proliferation of cells without affecting their immunophenotype or differentiation 
abilities. It also has comparable mechanical properties, biodegradation rate 
permeability, and flexibility to the tissue it intends to replace. Decellularized hAM is a 
versatile biomaterial that meets these criteria and can be used to engineer several types 
of tissues from the human body.7 The hAM is currently being investigated for a broad 
range of applications such as blood vessel tissue engineering,45 cartilage regeneration,46 
and urothelium tissue engineering.47  
 
Preservation and Decellularization Techniques 
Tissue Processing and Preservation 
The hAM can be used two ways, either intact with its epithelium layer or decellularized 
with its epithelium removed. An intact hAM would simply be detached from the 
chorion, cut to size, and preserved for upcoming applications. The epithelium 
monolayer and extracellular matrix would remain untouched. Intact membranes are 
typically used for wound dressing in clinical applications, while decellularized hAM are 
ideal scaffolds for tissue engineering constructs. Epithelial cells need to be removed 
from the hAM in order to not interfere with new cells seeded on the scaffold. The goal 
of the decellularization process is to remove all epithelial cells and obtain a uniform and 
smooth basement membrane.16,48,49 Figure 03 illustrates the removal of the epithelium 
layer after decellularization.50  
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Intact membranes for clinical applications are processed, sterilized, and preserved prior 
to implantation in humans. Tissue processing simply consists of mechanically 
separating the amnion from the chorion, cutting it into smaller pieces, and flattening it 
onto nitrocellulose paper. Tissue preservation helps provide a steady supply of scaffolds 
for clinical applications. Several protocols have been developed including 
cryopreservation in glycerol, air-drying, freeze-drying, and incubation in trehalose.48,51 
 
was made through a midline longitudinal incision and a
medial parapatellar approach, with the patella dislocated
laterally to expose the femoral condyles. To create the os-
teochondritis defect, a 5mm drill was used at patella groove.
Therewere a total of twenty-four condyles thatwere assigned
to three groups: (1) the null group, in which the defects were
not covered, (2) the control group, in which the defects were
covered only with a denuded HAM with its stromal layer
facing in, and (3) the experimental group, in which the de-
fects were covered with DHS with the seeded cells facing in
(after 1week of culture in vitro). Each group consisted of four
rabbits, and a total of four stifles were retrieved, using two
rabbits each at 4weeks and 8weeks after implantation. De-
nudedHAMandDHScovering the defectswere secured onto
the adjacent subchondral bone with nonabsorbable No.5
Nylon suture materials.
Examination of the defects. At 4 and 8weeks after sur-
gery, the animals were anesthetized by an overdose of pen-
tobarbital inject on to retrieve the femoral condyles. The
specimens were paraffin embedded, sectioned, and processed
for routine Safranin-O staining. In addition, the regenerated
cartilage was scored according to the International Cartilage
Repair Society (ICRS) Visual Histological Assessment
Scale.19
Statistical analysis
Statistical differences between the groups in the assays
were sought by using the one-way analysis of variance
(ANOVA) and student t test (two-tail). A statistical sig-
nificance was assigned as ***: p< 0.001.
RESULTS
In vitro experiments
Histology of intact and denuded HAMs. While Masson‘s
trichrome staining of intact HAM showed the epithelial cells
aligned on the surface (Fig. 2A), these cells were completely
removed, once treated with 0.1% trypsin-EDTA and subse-
quently scraped, in the denuded ham (Fig. 2B). The collagen
and PG contents in the intact HAMwere measured as 299.7!
53mg/mg and 36.3! 5.5mg/mg, respectively. Themajor com-
ponent of intact HAM was collagen (Fig. 2C). DNA was not
detected after enzyme treatment (Fig. 2D). Thus, it produced
a denuded surface at the basement membrane layer. The op-
posite side, the stromal layer, was not affected by enzyme
treatment as observed from morphological analysis and che-
mical measurement of collagen content. Collagen content was







































FIG. 2. Masson’s trichrome staining of (A) intact HAM and (B) denuded HAM ("200). The epithelium was completely removed
from the basement membrane by 0.1% trypsin-EDTA treatment to make the denuded HAM. The letters, e, b, and s denote epithelium,
basement membrane, and stroma, respectively. The collagen content in the intact HAM (IHE) was eight times the PG content (C). After
trypsin-EDTA treatment, DNA was almost completely removed, while the collagen content did not change significantly (D). Data were
presented as mean values! standard deviation (SD) from three independent experiments (n¼ 3). Color images available online at
www.liebertpub.com/ten.
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Figure 3: Histological comparison of (A) an intact hAM with (B) a hAM 
decellularized with 0.1% trypsin-EDTA. Th  letters, e, b, and s respectively 




hAM intended for tissue engineering applications are de-epithelialized. Rapid freezing 
is often used as a preli inary step to introduce ice crystals into the intracellular space 
and cause cell lysis.52 Enzymatic treatments and chemical treatments are then needed to 
solubilize the remaining cytoplasmic and nuclear cellular membranes.53 
 
Enzymatic treatments for decellularization include protease digestion, calcium chelating 
agents, and nucleases.54 Most protocols commonly use EDTA, dispase, trypsin, or 
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thermolysin.48,53,55 Saghizadeh et al also reported using NaOH to efficiently de-
epithelialize the hAM.56 Nucleases such as DNases and RNases are also advantageous 
for removing nucleotides after an initial cell lysis.54 Finally, sodium dodecyl sulfate is 
one of the most popular and attractive detergents used for treating the hAM since it 
yields a complete removal of cellular remnants without damaging the collagen from the 
tissue.54,57,58 
 
Gamma irradiation and chemical solutions (peracetic acid and ethanol) are the main 
techniques used for the sterilization of the hAM.58 Supercritical carbon dioxide has also 
been described as a preparation technique to obtain a sterile hAM without affecting its 
composition.59 
 
Commercially Available Products 
The advances realized these past decades for the stabilization, preservation, and storage 
of tissues also lead to the development of several commercially available products 
derived from the hAM.46,60 These products have the advantages of being stable, as well 
as easily transported and stored. A majority of them consist of either cryopreserved or 
dehydrated intact hAM and have been recommended for the treatment of ophthalmic 
and dermal wounds. Detailed information about commercially available hAM products 




Despite its attractive biological and biochemical properties, the hAM has been limited 
by its mechanical properties and biodegradation rate for some tissue engineering or 
regenerative medicine applications. To overcome these limitations, alterations to the 
hAM have been made to tune its properties, either through incorporating composite 
materials, chemical crosslinking, or innovative layering and tissue preparation strategies 
into the hAM. 
 
Crosslinking 
Chemical crosslinking of the hAM has been reported to improve its mechanical 
properties and biodegradation rate without affecting cellular response.61–67 Figure 04 
presents an innovative technique developed by Hariya et al. for the production of 
transparent and resilient crosslinked hAM tissue laminates.68 Carbodiimide was used for 
crosslinking and up to 8 layers were assembled to produce a tougher and optically 




Figure 4: Fabrication of transparent and resilient crosslinked hAM tissue 
laminates. For the first lamination stage, hAM are repeatedly dried and stacked up 
to produce a multilayer tissue laminate. Then, tissue constructs are optically 
clarified after successive carbodiimide crosslinking, washing, drying, and 
quenching steps. The final laminates contain up to 8 hAM layers and benefit from 




New preparation techniques and composite scaffold strategies have also emerged as 
ways to tune the properties of the hAM. Recent publications describe applications of the 
hAM for osteochondral tissue engineering by coating it with poly(lactic-co-glycolic 
acid).69 The hAM was mixed with fibrin to produce a tissue engineered blood vessel 
and was combined with collagen-glycosaminoglycan scaffolds for tendon tissue 
engineering.70,71 A similar composite material approach was used by Adamowicz et al. 
who layered denuded hAM with electrospun poly(L-lactide-co-e-caprolactone) (PLCL) 
for reconstructive urology.72 These composite scaffolds, presented in Figure 05, were 




Figure 5: Scanning electron microscopy images of hAM-PLCL composite 
scaffolds. A: Cross-section image of the composite scaffold. B: Delaminated 
composite. Frozen hAM was sandwiched and covered on both sides with two layers 
of electrospun PLCL. Adapted from Adamowicz et al.72 
 
Several more composite and preparation techniques have been used to functionally 
augment the hAM for tissue regeneration purposes.73 A decellularized hAM was 
assembled with electrospun silk fibroin to produce a 3D bilayer of artificial skin.74 
Denuded hAM was coated with poly(ester) urethane on both sides to improve its 
mechanical strength and produce a biocompatible surgical mesh.75 
 
Another popular preparation method is the combination of several hAM scaffolds to 
produce multilayer constructs such as the hAM tissue laminates presented in Figure 04. 
Multilayer constructs have been reported for the fabrication of tissue engineered blood 
vessels,70,76,77 surgical patches,78 applications in ophthalmology,68,79,80 and oral and 
maxillofacial surgery.81,82 Finally, skin defects have been treated with micronized hAM 





The hAM is widely used for a variety of ocular surface diseases thanks to its attractive 
biological properties, transparency, thinness, and composition akin to the one of the 
conjunctiva.85 The hAM can be applied on the ocular surface either as a temporary 
dressing or as a permanent graft.38 When used as a temporary biological bandage, the 
hAM acts as barrier to protect the healing epithelium from the movement of the eyelids. 
A hAM dressing aims to repel inflammation of the host tissue and reduce scarring.38 
 
A permanent hAM graft transplanted on the ocular surface is used to promote the 
proliferation of the epithelial cells present on the ocular surface.86 The patient’s cells 
will grow over the hAM and the scaffold will be integrated into the patient’s tissue. For 
deep corneal ulcerations or perforations, the hAM can also be stuffed into the defects 
prior to patching or grafting.87 
 
Today the hAM is widely used for the management of several ocular ailments of the 
cornea or the conjuctiva. Applications of the hAM for corneal surface reconstruction 
include the treatment of chemical burns, bullous keratopathy, persistent epithelial 
defects, ulcers, and lesions.87  The hAM has been adopted for a variety of conjunctival 
pathologies including symblepharon, pterygium, chemical burns, and scleral thinning, 




The hAM has also been applied to the treatment of limbal stem cell deficiency. Unlike 
the ophthalmic applications previously described, this recent method uses the hAM to 
produce a cellularized graft.90–92 Limbal stem cells are critical for the constant 
maintenance and regeneration of the corneal epithelium. Damage to the limbus would 
lead to the deficiency of these stem cells, epithelial breakdown, chronic inflammation, 
corneal conjunctivalization, and a loss of corneal clarity.93 Limbal stem cell deficiency 
can be treated with the transplantation of limbal epithelial cells expanded ex vivo. Cells 
can be obtained from a small biopsy of the patient’s other eye if healthy, or from 
another living individual or a cadaveric donor if both of the patient’s eyes are affected 
by limbal stem cell deficiency.93 In the case of donor shortages, oral mucosal epithelial 
cells and bone marrow mesenchymal stem cells could also be used as replacement cell 
sources to reconstruct the corneal surface.94–97 Decellularized hAM have been 
successfully used as substrates for the ex vivo expansion of limbal epithelial cells. 
Transplantation of these cellularized grafts resulted in the repopulation of the corneal 
epithelium and integration of the hAM with the corneal tissue.87,98,99 Figure 06 













Figure 6: Illustration of the transplantation process of autologous limbal epithelial 
cells for the treatment of a unilateral limbal stem cell deficiency. A small biopsy 
(about 2 by 2 mm of tissue) is performed on the patient’s healthy donor eye. 
Limbal epithelial cells are then isolated and seeded onto a sheet of decellularized 
hAM. After 2 to 3 weeks of culture, the cellularized hAM graft is transplanted onto 
the patient’s diseased corneal surface. 
 
Other recent innovations have been finding new ways to attach the hAM to the ocular 
surface. The hAM is a thin material that is typically attached to the corneal surface with 
sutures. However, hAM bandages need to be replaced every week and repeated 
interventions at the diseased corneal surface is not recommended. Possible side effects 
of sutures also include conjunctival bleeding or scarring.100 
 
The strategies developed for the sutureless fixation of the hAM include the use of 
fibrin,101,102 chemically defined bioadhesives,103,104 light-initiated bonding with Rose 
Bengal dye105,106 and medical devices (ProKera and AmnioClip) that use a dual ring 




The hAM has been described as an effective therapeutic option for burn wound 
dressing. Indeed, the hAM presents several advantages for skin applications such as its 
anti-inflammatory properties, antimicrobial effects, low immunogenicity, and good 
wound adherence. When used to cover burn wounds, the hAM reduced pain and scars, 
prevented infections, and promoted re-epithelialization. 108–110 
 
The hAM has been used to treat both superficial and partial-thickness burns,110 as an 
overlay for skin autografts, 111,112 and as a dressing for skin graft donor sites.113,114 
Besides burn wound dressing, the hAM proved effective for the treatment of chronic leg 
ulcers, pressure sores, and for patients with epidermolysis bullosa.115–117 
 
These long-established dermatology applications of the hAM involve using it as an 
acellular biomaterial, while the most recent studies report using the hAM for the 
attachment and proliferation of various cell lines. Patients with stable vitiligo were 
transplanted with autologous melanocytes seeded on a decellularized hAM, resulting in 
over 90% skin repigmentation.118,119 Skin equivalents were constructed by combining a 
hAM seeded with fibroblasts and normal keratinocytes.65,120,121 Biological wound 
dressings were designed to promote tissue regeneration for patients with full-thickness 
skin defects, by combining the hAM with mesenchymal stem cells.11,83,122 
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Oral and Maxillofacial Surgery 
After oral surgery, bone surfaces are often exposed to the oral cavity which can lead to 
possible infections and scar formation. Thanks to its biological properties, the hAM has 
been described as an effective scaffold for the reconstruction of the oral cavity.42 
Consequently, the hAM has been used for a broad range of applications: treatment of 
oral mucosa defects after removal or cancerous legions,123 flap surgery, 124 oronasal 
fistula reconstruction in cleft palate surgery,81,82 and temporomandibular joint 
surgery.125 
 
Recent tissue engineering approaches involve the fabrication of a myomucosal flap 
using oral keratinocytes cultured on hAMs,126 and the autologous transplantation of oral 
mucosal epithelial cell sheets cultured on hAMs for intraoral mucosal defects.127–129 
Figure 07 shows that oral mucosal epithelial cells cultured on the hAMs present 




Figure 7: Comparison of hAM-cultured oral mucosal epithelial cells with the oral 
mucosa. A-F: hematoxylin and eosin staining. B-G, C-H, D-I, E-J: Expression of 
keratins 4, 13, 1, and 10 in green with the cell nuclei stained in red with propidium 
iodide. Keratin expression was similar between the hAM cultured oral mucosal 




The human amniotic membrane has shown therapeutic promises as a scaffold in 
otolaryngology. Patches of hyperdry hAM were used as dressing substitutes for fascia 
grafts of the temporal muscle in canal wall down tympanoplasty.130,131 The hAM grafts 
were completely epithelialized faster than the classic fascia grafts.  
 
Tissue Engineering Applications 
The hAM has been investigated as a scaffold for tissue engineering and regenerative 
medicine applications in a broad range of disciplines. Several of these studies were 
already reported in previous paragraphs dedicated to tissue modifications of the hAM, 
along with novel cellularized applications of the hAM in ophthalmology, dermatology, 
and oral and maxillofacial surgery. 
 
Articular cartilage has minimal self-healing capability and often advances to 
osteoarthritis once damaged.132,133 The hAM has been described as an ideal substrate for 
the culture of chondrocytes.134–137 Consequently, chondrocytes have been seeded on the 
HAM in order to obtain a delivery vehicle for cell transplantation that could promote 
cartilage regeneration in vivo. For instance, Jin et al. seeded rabbit articular 
chondrocytes on decellularized hAM and used these constructs in vivo to cover rabbit 




The hAM has been reported as a potential osteoinductive biomaterial for bone 
regeneration.138,139 Decellularized hAM helped induce the osteogenic differentiation of 
human dental apical papilla cells seeded on top of it, opening potential applications for 
the hAM in bone and tooth tissue engineering.140 Intact hAM simply exposed to 
osteogenic media also promoted the differentiation of the stem cells contained in the 
hAM towards osteogenic pathways.141 
 
In the past years, the hAM has been investigated as a scaffold for tissue engineering of 
the urinary tract system. The hAM was described as a viable scaffold for the culture of 
urothelial cells and the reconstruction of damaged urothelium tissue.47,142–144 
 
The hAM has been characterized as blood compatible and as an adequate cell carrier 
matrix for endothelial and smooth muscle cells.76,145,146 Consequently, several studies 
have reported rolling the hAM to engineer small diameter blood vessels.45,70,76,77,147 
 
Finally, the hAM has been used as a scaffold for salivary gland regeneration,148 for 
esophageal wall tissue engineering,149 for the treatment of pelvic floor dysfunction,150 
for liver regeneration, 151,152 and as a support of in vitro ovarian follicular culture.153 
 
Limitations 
Risk of disease transmission 
Due to its human origin, the hAM carries a risk of disease transmission from its donor. 
Consequently, the use of fresh untreated hAM is not recommended. The collection, 
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processing, and transplantation of the hAM have to follow the proper laws and 
regulations of the country where they would be performed.46  
 
To avoid bacterial contamination, it is recommended to collect hAM tissue after 
caesarean section under sterile conditions. Typically, serological testing for syphilis, 
hepatitis, and HIV are performed on the donor at the time of tissue collection.87 
Serological screening is repeated 6 months after birth to confirm that there were no false 
negatives during the first round of testing. In the meantime, the hAM is quarantined 
until both results are negative. Then, the hAM needs to be processed under aseptic 
conditions and stored in a sterile environment.87,98 
 
Donor variation 
The hAM is a biological human tissue and its composition is affected by intra and inter 
donor variations.86,154 The fetal sex, gestational age, donor age, health, and diet are all 
parameters that affect the properties of the hAM. Between donors, the thickness of the 
hAM varies from 20 to 50µm.1,2 From the same donor, the hAM will also be thinner 
away from the placenta and thicker closer to the umbilical cord.155 The transparency of 
the hAM will also change depending on its original location in the amniotic sac.156 One 
possibility to overcome these donor variations would be the development of pooling and 




Effects of decellularization and storage techniques 
The preservation, decellularization, and sterilization protocols used to process the hAM 
will affect its mechanical properties, transparency, chemical composition, and cell 
adhesion properties.48,157–160 Characterizing how a treatment influences the morphology 
and composition of the hAM helps verify that no undesirable or unwanted property 
changes were induced. For instance, it is critical to ensure that the cell adhesion 
properties of the hAM are maintained after processing if the hAM is intended for tissue 
engineering applications. 
 
Standardization of processing techniques helps reduce variability. Standard protocols 
developed for commercially available hAM products and for tissue banks help produce 
consistent hAM allografts for clinical applications.60,161–163 
 
Conclusion 
The hAM is a readily available and inexpensive biomaterial that can efficiently be 
processed, preserved, and de-epithelialized. Thanks to its unique set of biological 
properties, the hAM is now a material of choice for several clinical applications in 
ophthalmology, dermatology, and oral and maxillofacial surgery. The development of 
standard processing protocols and tissue banks, along with commercially available 
hAM derived products, will further expand the clinical applications of the hAM. 
 
Moreover, decellularized hAM has proven worthwhile for a broad range of tissue 
engineering applications due to its ability to support cell attachment, proliferation, and 
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differentiation. Modifications of the hAM have been developed to tune its properties, 
either through composite materials incorporating the hAM, chemical crosslinking, or 
innovative layering and tissue preparation strategies. Additionally, the hAM has been 
identified as a source of human amniotic epithelial cells and human amniotic 
mesenchymal stromal cells. These two multipotent cell lines are valuable for tissue 
engineering and regenerative medicine applications. 
 
Overall, the hAM is truly a versatile biomaterial and its foreseeable future as a scaffold 





Chapter 3: Characterization of Riboflavin-UVA Crosslinking of 
Amniotic Membranes and its Influence on the Culture of Adipose-





The human amniotic membrane (hAM) is a collagen-based extracellular matrix whose 
applications are restricted by its moderate mechanical properties and rapid 
biodegradation. In this work, we investigate the use of riboflavin, a water-soluble 
vitamin, to crosslink and strengthen the human amniotic membrane under UVA light. 
The effect of riboflavin-UVA crosslinking on hAM properties were determined via 
infrared spectroscopy, uniaxial tensile testing, proteolytic degradation, permeability 
testing, SEM, and quantification of free (un-crosslinked) amine groups. Samples 
crosslinked with glutaraldehyde, a common and effective yet cytotoxic crosslinking 
agent, were used as controls. Improved hAM mechanical properties must not come at 
the expense of reduced cellular proliferation and induction capabilities. In this study, we 
assessed the viability, proliferation, immunophenotype, and multilineage differentiation 
ability of human adipose-derived stem cells seeded on riboflavin-UVA crosslinked 
membranes. Overall, hAM crosslinked with riboflavin-UVA benefited from a stable 
2.5-fold increase in mechanical properties (comparable to the increase seen with 
glutaraldehyde crosslinked membranes) and improved biodegradation, all while 
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retaining their biocompatibility and abilities to support the cultivation and 
differentiation of adipose-derived stem cells. Together, these results suggest that 
riboflavin-UVA crosslinking is an effective strategy to enhance the hAM for tissue 




The human amniotic membrane (hAM) is a collagen-based extracellular matrix derived 
from the human placenta. It is a readily-available, inexpensive, and naturally 
biocompatible material 7,27. Thanks to its anti-inflammatory properties and low 
immunogenicity 8,164, the hAM is now commonly used in a broad range of medical 
fields. Recent in vivo studies report the successful implantation of hAM to reconstruct 
the oral mucosa 128, patch skin ulcers 11, wrap transected nerves 165,166, and produce 
biological meshes 75, tissue engineered urothelium 47, esophageal wall 167, and liver 
tissue 168. Furthermore, due to its transparent structure and ability to provide a substrate 
for the growth of corneal and epithelial cells, the hAM is also an ideal biomaterial for 
ocular surface reconstruction 87, having proven effective in transplanting ex vivo 
cultivated limbal epithelial stem cells for the treatment of limbal stem cell deficiency in 
a number of human subjects 169. For many applications, however, the mechanical 
properties of the hAM are not consistent with the mechanical properties of the tissue it 
is attempting to replace. 
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Chemical crosslinking is a well-documented technique to stabilize extracellular matrix 
components, improving the mechanical properties of a scaffold and decreasing its 
biodegradation rate 170,171. The major components of the hAM are collagens type I and 
III, and consequently, various crosslinking agents such as glutaraldehyde 61,172,173 and 
carbodiimide 62,67 have been used to chemically crosslink the hAM. These crosslinking 
techniques were effective at improving the mechanical properties of the scaffolds. 
However, the crosslinking agents used were highly cytotoxic, resulting in 
biocompatibility issues with the resulting scaffolds 171,174. 
 
Riboflavin, or vitamin B2, is a water-soluble vitamin 175,176 that has been reported as a 
naturally occurring and non-cytotoxic crosslinking agent when combined with UV light. 
It has previously been used to crosslink collagen hydrogels 177–179 and corneal collagen 
180,181. Furthermore, after over a decade of successful clinical trials, riboflavin-UVA is 
now an FDA approved treatment for keratoconus 182, a disease that causes thinning of 
the corneal stroma 183,184.  
 
In this study, we investigate the potential of using riboflavin-UVA to crosslink the hAM 
and examine its influence on the cultivation of human adipose-derived stem cells 
(hASCs). hAM were crosslinked with different concentrations of riboflavin and 
characterized by FTIR, free amine group quantification, uniaxial tensile testing, 
proteolytic degradation, and permeability measurements. Membranes crosslinked with 
glutaraldehyde were also used as a control for all experiments. The influence of 
crosslinked hAM on the cultivation of mesenchymal stem cells still remains to be 
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studied since previous studies focused on the cultivation of epithelial cells for 
ophthalmology applications 62,173,185. In this work, the effect of riboflavin-UVA 
crosslinking on the cultivation of human adipose-derived stem cells (hASCs) was 
examined. Cell viability/cytotoxicity and proliferation assays were conducted to 
evaluate the effect of riboflavin-UVA crosslinking on cellular adhesion and 
proliferation. The immunophenotype of hASCs cultivated on crosslinked hAM was 
determined by flow cytometry analysis of CD29, CD34, CD44, CD45, CD73, CD90, 
and CD105 cell surface markers. Finally, the adipogenic, osteogenic, and chondrogenic 
differentiation of hASCs seeded onto crosslinked and noncrosslinked membranes was 
also examined.  
 
Materials and Methods 
 
De-Epithelialization of the Human Amniotic Membrane 
Placentas were collected from the Labor and Delivery unit at Norman Regional Hospital 
(Norman, OK) five days after birth following procedures that were approved by the 
Institutional Review Boards of both the hospital and the University of Oklahoma. The 
hAM was then extracted and processed following established protocols 57,76. Briefly, the 
hAM was stripped from the chorion, rinsed with deionized water and cut into smaller 
pieces to ensure proper exposure to the subsequent de-epithelialization treatments. After 
two freeze-thaw cycles, the membranes were transferred to a solution of 0.03% (w/v) 
sodium dodecyl sulfate (J.T. Baker, Center Valley, PA) in deionized water for 12 to 24 
hours. Tissues were then incubated in a solution of 50 U/mL of DNase (Sigma-Aldrich, 
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Saint-Louis, MO) in Tris base for 2 hours at 37°C. Finally, the membranes were 
sterilized in 0.2% (v/v) peracetic acid (Sigma-Aldrich) and 4% (v/v) ethanol in 
deionized water for 2 hours and stored in phosphate buffered saline (PBS) at 4°C. 
Between each treatment, membranes were rinsed five times with deionized water to 
remove any remaining chemicals. All steps were performed in 500mL bottles on an 
orbital shaker at 100 rpm to ensure full exposure for each of the membranes. 
 
Chemical crosslinking of membranes 
Decellularized amniotic membranes were submerged in solutions of riboflavin (Sigma-
Aldrich) at different concentrations and exposed to UV light at 366 nm on a 
transilluminator (Fotodyne, Hartland, WI) with an intensity of 4mW/cm2. Exposure 
time to the UV light was 60 min and concentrations of riboflavin ranged from 0.001 to 
0.1 g/L. As a control, some amniotic membranes were also crosslinked in a 10mM 
solution of glutaraldehyde for 60 min. All crosslinked samples were thoroughly washed 
with phosphate buffered saline to remove any residual crosslinking agents before use. 
 
Determination of the crosslinking degree 
To evaluate the extent of crosslinking, free amino groups were detected by reaction with 
ninhydrin 186. Each tissue sample was boiled in a ninhydrin reagent solution (Sigma-
Aldrich) for 20 min. After cooling (to room temperature), the solution was diluted in 
95% ethanol and its optical absorbance measured with a Synergy HT microplate reader 
at 570 nm (BioTek Instruments, Winooski, VT). Standards were prepared using glycine 
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at different concentrations. The amount of free amines in a sample was proportional to 




Where X0 and X1 represent the amount of free amine groups in a noncrosslinked and 
crosslinked sample, respectively 62,187.  
 
Fourier Transform Infrared Spectroscopy (FTIR) 
IR spectra were recorded on a Shimadzu IRAffinity-1 FTIR spectrometer (Shimadzu, 
Kyoto, Japan) in the 4000 to 450 cm-1 range with 25 scans at a resolution of 4 cm-1. 
Shimadzu IRsolution version 1.10 was used for data acquisition and Essential FTIR 
version 3.50 (Operant LLC, Madison, WI) for data processing and analysis. 
 
Mechanical testing  
Mechanical properties were assessed using a United Smart Table SSTM-2 uniaxial 
tensile testing frame (United, Flint, MI) equipped with a 5kg load cell. Sample gauge 
length was 30 mm and width was 20 mm. Each sample was mounted between two 
pneumatic grips and preloaded to 5 g of force for 10 seconds before being stretched 
until failure at a crosshead speed of 5mm/min. Stress-strain curves were acquired using 
the software Datum 3.0 (United) and subsequently used to determine the Young’s 
modulus and ultimate tensile strength of the tested samples. 
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In vitro degradation and water content 
Membranes were dried, weighed, and then incubated in a solution of PBS at pH 7.4 
containing 5 U/mL of collagenase type I (Gibco, Carlsbad, CA) supplemented with 1% 
(w/v) BSA. This enzymatic digestion was performed at 37°C on an orbital shaker at 100 
RPM to ensure full exposure of the membranes to the collagenase. Samples were dried 
and their weight recorded at different time points for up to 48 hours. The water content 
of a membrane was determined by measuring its weight after drying and after swelling 
in deionized water. 
Permeability measurement 
A custom-made diffusion chamber was used to evaluate the permeability of the 
membranes.188,189 Each chamber surrounding the sample had a diameter of 20 mm and a 
volume of 6.3 mL. 30 x 30 mm square membranes segments were secured between the 
two chambers. Glucose at a concentration of 1.0 mg/mL was loaded in the first chamber 
while the second one was filled with nanopure water. 10 µL samples were taken from 
both chambers every 15 min until equilibrium was reached. Samples were then 
incubated for 15 min at room temperature with 100 µL of glucose hexokinase assay 
reagent (Sigma-Aldrich) and their absorbance measured at 340 nm to determine the 
concentration of the samples. A quasi steady-state was assumed and the hAM was 
considered as a thin membrane to calculate the coefficient of diffusion Deff. 188,190 The 
permeability of the hAM to glucose was then obtained by dividing Deff by the thickness 
of the hAM.189 
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Scanning Electron Microscopy 
Amniotic membrane samples were washed in PBS, treated in 1% (v/v) osmium 
tetroxide (Sigma-Aldrich) in PBS for 2 hours, and then dehydrated in a graded ethanol 
series. Samples were then critical point dried and sputter-coated with gold before 
observation. Images were obtained using a Zeiss NEON 40EsB high resolution 
scanning electron microscope at 5 keV (Carl Zeiss Microscopy, Thornwood, NY, 
USA). 
 
Stem cell culture 
Human adipose-derived stem cells (hASCs) were provided by Dr. Jeffrey Gimble from 
Tulane University. They were cultured in Dulbecco's Modified Eagle Medium: Nutrient 
Mixture F-12 media (DMEM/F-12, Gibco) supplemented with 10% fetal bovine serum 
(Gemini Bio-Products, West Sacramento, CA) and 1% antibiotic-antimycotic (Gemini). 
Cell culture flasks were kept in a humidified incubator at 37°C with 5% CO2.  
 
Cell viability and proliferation assays 
hASCs at passage 1 were seeded onto the stromal side of hAM at a density of 500 
cells/mm2. 72 hours after, cell viability was assessed using a LIVE/DEAD 
Viability/Cytotoxicity kit (Invitrogen, Carlsbad, CA) according to the manufacturer’s 
recommendations. Briefly, tissue samples were washed with PBS, and incubated at 
room temperature for 45 min with a 2 µM calcein AM and 4 µM Ethidium homodimer-
1 working solution. Samples were then imaged using a Nikon Eclipse E800 
36 
fluorescence microscope (Nikon Instruments Inc., Melville, NY, USA). ImageJ version 
1.50i (NIH, Bethesda, MD) was used for image processing.  
 
hASCs at passage 1 were seeded onto the stromal side of hAM at a density of 500 
cells/mm2. On day 1 and day 7 after seeding, 25 by 25 mm hAM samples were digested 
in collagenase type I (30 U/mL in PBS supplemented with 1% BSA) overnight at 37°C, 
sonicated, and then submitted to three freeze-thaw cycles to release the DNA content of 
the cells. A Quant-iT PicoGreen dsDNA assay kit (Invitrogen) was used according to 
the manufacturer’s recommendations to quantify the amount of dsDNA per sample. The 
total cell number in a sample was then obtained by dividing the amount of dsDNA in a 
sample by the previously-determined mean dsDNA content per cell (6 pg). 
 
Flow cytometry analysis 
All reagents used for flow cytometry analysis were obtained from BD Biosciences, San 
Jose, CA. hASCs at passage 1 were seeded onto the stromal side of crosslinked and 
noncrosslinked hAM at a density of 500 cells/mm2. After 72 hours, cells were harvested 
from the membranes after incubation with TrypLE Express (Gibco) for 10 min. 
Aliquots of 105 cells were incubated on ice for 20 min with monoclonal antibodies 
directed against CD29 (phycoerythrin (PE)-conjugated), CD34 (fluorescein 
isothiocyanate (FITC)-conjugated), CD44 (PE-conjugated), CD45 (PE-conjugated), 
CD73(PE-conjugated), CD90(FITC-conjugated), and CD105 (FITC-conjugated). The 
appropriate isotype controls (PE-conjugated Ms IgG1, κ, and FITC-conjugated Ms IgG1, 
κ) and an unstained cell sample were also used to respectively measure non-specific 
37 
binding and autofluorescence background. After incubation, cells were washed with 
PBS supplemented with 1% FBS and 0.1% sodium azide. 104 events were recorded for 
each sample on a BD Accuri C6 flow cytometer (BD Biosciences). Data was analyzed 
using FCS Express 6 Plus (De Novo Software, Glendale, CA). 
 
Multilineage differentiation 
hASCs at passage 1 were seeded on the stromal side of hAM at a density of 500 
cells/mm2. Adipogenic, osteogenic, and chondrogenic differentiation was then 
performed using commercially available differentiation medium kits (Gibco) and 
following the manufacturer’s recommendations. After 14 days in culture, hASCs 
exposed to adipocyte differentiation medium were washed in PBS and fixed at 4°C with 
10% formalin for an hour. Cells were then washed with DI water and incubated at room 
temperature for 20 min with a 0.5% Oil Red O solution in isopropanol (Sigma-Aldrich) 
to stain the cells for lipid accumulation. After a 14-day differentiation period, hASCs 
exposed to osteogenic differentiation medium were washed in PBS and fixed at 4°C 
with 70% ethanol for an hour. Cells were then washed with DI water and incubated at 
room temperature for 10 min with a 2% alizarin red S solution (Sigma-Aldrich) to stain 
calcium deposits. After 28 days in culture, hASCs exposed to chondrogenic 
differentiation medium were washed in PBS and fixed at room temperature with 10% 
formalin for 15 min. Cells were then washed with DI water and incubated at 37°C for 
30 min with a 1% alcian blue solution in 3% acetic acid (Sigma-Aldrich) to stain for for 
glycosaminoglycans. Images were then obtained using an Olympus CKX41 (Olympus, 




All quantitative results are expressed as mean values ± standard error of the mean 
(SEM). Sample size (n) is indicated in each figure legend. Statistical analysis was 
performed via one-way analysis of variance (ANOVA) with Tukey’s post hoc testing, 





Characterization of the riboflavin-UVA crosslinking reaction 
All the hAM used in these experiments were decellularized prior to usage by following 
previously established protocols 57,76, resulting in 50 µm thick membranes from which 
the pre-existing monolayer of epithelial cells was completely removed. Five different 
groups were compared throughout this study: simple noncrosslinked membranes (NON 
group), membranes crosslinked with 0.001, 0.01, and 0.1 g/L riboflavin which were 
respectively referred to as the RB Low, RB Med, and RB High groups, and hAM 
crosslinked with glutaraldehyde at 10 mM, designated as the GLU control group. This 
glutaraldehyde concentration is in the neighborhood of previously reported crosslinking 
protocols with glutaraldehyde,61,172,173 and has the advantage of producing crosslinked 
hAM with a comparable crosslinking degree than the highest riboflavin concentration 
used (RB High). 
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The FTIR spectra of all groups are displayed in Figure 8. FTIR is representative of the 
entire thickness of a membrane since the light beam is transmitted through the tissue 
sample. All spectra presented a similar pattern, comparable to previously reported FTIR 
spectra for the hAM.59,62 Characteristics absorption bands were observed at 3316 cm-1 
(N-H stretching), 2923 cm-1 (C-H stretching), 1654 cm-1 (amide I, C=O stretching), 
1552 cm-1 (amide II, N-H bending),1239 cm-1 (amide III, N-H bending). Lower 
intensity peaks were present on spectra for crosslinked hAM compared to 
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Figure 8: FTIR spectra of noncrosslinked and crosslinked hAM (n=4). 
Characteristics absorption bands were at 3316 cm-1 (N-H stretching), 2923 cm-1 (C-
H stretching), 1654 cm-1 (amide I, C=O stretching), 1552 cm-1 (amide II, N-H 




Furthermore, ninhydrin was used for the quantification of free amine groups in 
noncrosslinked and crosslinked membranes. The crosslinking degree for these samples 
is reported in Figure 9. Crosslinked membranes contained lower concentrations of free 
amine groups, hence presenting a higher crosslinking degree of up to 42.9±3.6% for 
hAM crosslinked with a high concentration (0.1% w/v) of riboflavin. The crosslinking 
degree of the glutaraldehyde crosslinked hAM (46.4±3.3%) was comparable to the one 
obtained with the highest concentration of riboflavin. The ninhydrin reactivity is not 
directly proportional to the amount of crosslinking but proportional to the number of 
free amino groups occupied. It is possible for a low concentration of riboflavin to 
already react and crosslink all possible reaction sites. Adding more riboflavin with a 
higher concentration could just bind riboflavin instead of crosslinking it. In this case, 
the extent of crosslinking would go up because more free amino groups are occupied 

































Figure 9: Crosslinking degrees determined by ninhydrin assay of hAM exposed to 
UVA-riboflavin or glutaraldehyde crosslinking as compared to noncrosslinked 
hAM (n=6 per group). *Significant differences (p < 0.05) when compared to RB 
Med, RB High, and GLU groups. ^Significant differences (p < 0.05) when 
compared to RB Low, RB High, and GLU groups. #Significant differences (p < 
0.05) when compared to RB Low, RB Med, and GLU groups. 
 
 
Results obtained via FTIR and quantification of free amino groups via ninhydrin assay 
correlate and indicate that exposure of hAM to riboflavin and UVA crosslink the 
membranes, with amino groups from the hAM collagen participating in the riboflavin-
UVA crosslinking reaction.191 
 
Evaluation of mechanical properties 
The tensile properties of crosslinked and noncrosslinked membranes are reported in 
Figure 10. A significant increase in Young’s Modulus and Ultimate Tensile Strength 






































































Figure 10: Mechanical properties of noncrosslinked and crosslinked hAM. (a) 
Young’s Modulus. *Significant differences (p < 0.05) when compared to NON 
group. (b) Ultimate Tensile Strength. *Significant differences (p < 0.05) when 
compared to NON and RB High groups. 
 
 
Proteolytic degradation and water content 
To measure the effect of crosslinking on the biodegradation rate, crosslinked and 
noncrosslinked membranes were exposed to a 5U/mL solution of collagenase type I in 
PBS on an orbital shaker at 37°C. After 48 hours of collagenase exposure, only 
10.0±3.8% of the original weight of the noncrosslinked membrane remained, as 
opposed to 69.5±4.9% for the hAM crosslinked with glutaraldehyde, as displayed in 
Figure 11. hAM crosslinked with low, medium, and high concentrations of riboflavin 
respectively maintained 22.3±3.9%, 35.5±4.4%, and 46.8±3.8% of their original 
weights. While exhibiting a lower degree of crosslinking than the GLU group, the RB 
groups still achieved a 2-fold, 3-fold, and 4-fold increase in biodegradation rate when 




























Figure 11: Enzymatic digestion of hAM by collagenase over time (n=6 per group). 
 
Another parameter to characterize the extent of the crosslinking reaction is the water 
content of membranes. Collagen crosslinking implies changes to the structure of 
collagen fibers, often bringing them closer together and causing a loss of water. The 
water content of crosslinked and noncrosslinked hAM is reported in Figure 12. The 
values obtained are consistent with the crosslinking degrees values shown in Figure 9: 
the more crosslinked membranes see a larger decrease in water content. However, the 
maximum loss of water content for a crosslinked hAM compared to a noncrosslinked 
































Figure 12: Water content (n=6 per group) of hAM. ^Significant differences (p < 
0.05) when compared to RB High and GLU groups. *Significant difference (p < 
0.05) when compared to NON and GLU groups. #Significant differences (p < 0.05) 





The effects of riboflavin-UVA and glutaraldehyde crosslinking on the glucose 
permeability of the hAM are displayed in Figure 13. Glucose is a critical component to 
ensure cell survival and proliferation and a high permeability is essential to avoid mass 
transport limitations. The permeability of noncrosslinked membranes was 59.6±3.8 x10-
6 cm2/sec, compared to 51.6±4.5 x10-6 cm2/sec, 49.8±3.2 x10-6 cm2/sec, 48.5±5.0 x10-6 
cm2/sec, and 52.3±4.2 x10-6 cm2/sec for membranes crosslinked with low, medium, 



















































* * * *
 
Figure 13: Glucose permeability of noncrosslinked and crosslinked hAM. 
*Significant difference (p < 0.05) when compared to NON group. 
 
 
Surface morphology of crosslinked hAM 
Scanning electron microscopy (SEM) was used to evaluate the effect of crosslinking on 
the surface morphology of hAM. Representative SEM images are provided in Figure 
14. The morphologies of RB Low, RB Med, RB High, and GLU crosslinked samples 
appear to be different than the NON group. Images of crosslinked samples showed 
some differences when compared to images of noncrosslinked membranes, but the 
differences were subtle and difficult to distinguish. Image analysis was not deemed a 
fruitful approach to quantify differences between the crosslinking groups due to the 
variability of images for the same group. Variations of collagen fibers volume between 
the groups would have also been very small and hard to quantify. Slight differences in 
the chemistry used to crosslink the hAM between the riboflavin-UVA and 
glutaraldehyde protocols would result in slightly different porosities. These differences 
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would be consistent with the water content and permeability results reported in Figures 
12 and 13.  
 
NON RB Low RB Med
RB High GLU
 
Figure 14: Representative scanning electron microscopy (SEM) images of the 
stromal side of crosslinked and noncrosslinked hAM membranes. Scale bars 
represent 1 µm. 
 
 
hASCs viability and proliferation 
hASCs at passage 1 were used to evaluate the cellular compatibility of crosslinked 
hAM. All cells were seeded on the stromal side up of the membranes, which presents a 
more favorable arrangement of collagen fibers compared to the epithelial side up.76 
Representative LIVE/DEAD pictures of hASCs cultivated for 72 hours on crosslinked 
and noncrosslinked hAM are shown in Figure 15. No visible differences were present 






Figure 15: Representative LIVE/DEAD staining of hASCs seeded on hAM 
scaffolds. Live cells fluoresce in green (stained with calcein AM) while dead cells 
fluoresce in red (Ethidium homodimer-1 staining). Scale bars represent 100 µm. 
 
 
Human adipose-derived stem cells (hASCs) adhered and proliferated to the surface of 
crosslinked and noncrosslinked membranes as demonstrated on Figure 16 by a 
quantification of cells per scaffold on Day 1 and Day 7 after seeding, as determined via 
a PicoGreen dsDNA assay. No significant differences in cell growth over time were 









































* * * * *
 
Figure 16: Average number of hASCs on crosslinked and noncrosslinked hAM at 
Day 1 and Day 7 after initial seeding of 300 000 cells per construct. *Significant 
difference (p < 0.05) when compared to Day 1 number of cells for the same group. 
 
 
Immunophenotype of hASCs cultivated on membranes 
The immunophenotype of hASCs seeded, grown for 72h, and detached from 
noncrosslinked and crosslinked hAM is reported in Figure 17. Cells were detached 
using TrypLE Express instead of more stronger dissociation agents (such as Trypsin-
EDTA) in order to not interfere with the expression of cell surface markers. All cells 
analyzed presented a comparable immunophenotype, independent of the type of 
membrane they were cultivated on. Consequently, for better clarity, only the 
immunophenotype of cells seeded on noncrosslinked membranes is fully reported in 
Figure 17.  
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Figure 17: Immunophenotype of hASCs cultivated on noncrosslinked hAM for 72 
hours, as determined by flow cytometry analysis. Isotype control antibodies are 
represented by a grey line and hASCs by a red line. Relative fluorescence on the X 
axis and counts on the Y axis. 
 
The immunophenotype of hASCs was consistent with previous reports.192,193 CD29, 
CD34, CD44, CD73, CD90, and CD105 were positively expressed while CD45 was not 
expressed. These results demonstrate that the stemness of the hASCs was not influenced 
by the microstructure changes induced by crosslinking.  
Similar gating strategies were applied to each sample in order to obtain comparable 
data. The median fluorescence intensity (MFI) was determined for each cell surface 
marker and for each membrane type that hASCs were cultivated on as displayed in 
Figure 18. When compared to the MFI for cells cultivated on noncrosslinked 
membranes, comparable results were obtained for cells grown on crosslinked scaffolds. 
These results are in agreement with the ones displayed in Figure 16 where the type of 






























































Figure 18: Median Fluorescence Intensity (MFI) of stem cell surface markers for 
cells cultivated on crosslinked membranes for 72 hours. MFI is relative to the MFI 
of cells cultivated on noncrosslinked hAM for 72 hours (n=4 per group). 
*Significant differences (p < 0.05) when compared to RB Med, RB High, and GLU 
groups. ^Significant difference (p < 0.05) when compared to RB Low, RB High, 
and GLU groups. #Significant differences (p < 0.05) when compared to RB Low, 
RB Med, and GLU groups. +Significant differences (p < 0.05) when compared to 




To evaluate if the differentiation abilities of hASCs were affected by the type of 
membrane they were cultivated on, hASCs were seeded on both noncrosslinked and 
crosslinked membranes and exposed to adipogenic, osteogenic, and chondrogenic 
differentiation media for 14, 14, and 28 days respectively. The type of membrane used 
for the cultivation of hASCs did not influence their differentiation abilities as displayed 
in Figure 19. Cells exposed to adipogenic differentiation media stained positive for lipid 
accumulation with Oil Red O. Calcium deposits were stained positively with alizarin 
red for cells cultivated with osteogenic differentiation media. Finally, chondrogenic 
nodules characterized by alcian blue staining were present after 28 days for hASCs 










(Oil Red O staining)
NON RB Low RB Med RB High GLU
 
Figure 19: Multilineage differentiation of hASCs seeded on noncrosslinked and 
crosslinked hAM. Differentiation of hASCs into adipocytes was demonstrated by 
positive Oil Red O staining. Differentiation into osteoblasts was shown by positive 
Alizarin red staining. Differentiation into chondrogenic nodules was characterized 
by alcian blue staining. 
 
Discussion 
Naturally occurring materials have been used as scaffolds in a wide range of tissue 
engineering applications 194,195. Although they typically provide excellent 
biocompatibility, the mechanical properties of these materials are often significantly 
less than that of the tissue they are intended to replace. To overcome this limitation, 
many investigators have resorted to some form of crosslinking of the natural material 
which generally improves the mechanical properties. However, in vivo studies have 
suggested that even very small amounts of unreacted residual crosslinking agents in the 
material can lead to substantial immunological complications 171,196. Our motivation for 
this study was that riboflavin-UVA crosslinking has been previously used clinically and 
did not show biocompatibility issues. Although the hAM is currently being used for a 
number of surgical procedures and riboflavin-UVA crosslinking of the cornea is FDA 
approved, there has not previously been a thorough and careful assessment of 
riboflavin-UVA crosslinked hAM. The goal of this study was to investigate the effect of 
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riboflavin-UVA crosslinking on the hAM and evaluate its effect on the cultivation of 
human adipose-derived stem cells. 
 
The extent of crosslinking was characterized in two different ways, by FTIR and by 
ninhydrin assay which determines the number of free amine groups. Both of these 
assays demonstrate a dose dependent increase in the extent of crosslinking as the 
riboflavin concentration is increased. These chemical characterizations of the treated 
hAM are consistent with the measurements we made of several physical properties of 
the membranes. As the extent of crosslinking goes up the water content and the 
permeability of the hAM goes down. This is a less desirable consequence of 
crosslinking, since these changes have been associated with poorer performance of 
tissue engineered constructs. On the other hand, crosslinking does significantly improve 
the mechanical properties of the hAM, essentially to the same strength as 
glutaraldehyde treated membranes.  
 
Cell attachment and growth can be very sensitive to subtle alterations in the chemical 
and physical properties of the substrate 197. To test the suitability of riboflavin-UVA 
crosslinked hAM for future applications using stem cells, we seeded native and 
crosslinked membranes with human adipose-derived stem cells. The cells adhered to 
and retained their stem cell-like character based on the expression of seven specific cell 
surface markers. While this data showed that stem cells would not be induced to 
differentiate towards some particular cell type when placed on the crosslinked 
membranes, we still needed to show that these stem cells retained their ability to 
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differentiate when exposed to the appropriate conditions. We then examined three well 
established differentiation protocols, leading cells towards either an adipogenic, 
osteogenic, or chondrogenic cell lineage. We found no differences in the ability of the 
cells to differentiate based on the type of membrane they were seeded on. This suggests 
that although the riboflavin-UVA treatment does change the chemical and physical 
properties of the hAM, the membrane retains its ability to support stem cell attachment 
and appropriate cell differentiation.  
 
Taken together, these results show that riboflavin-UVA crosslinked hAM performed 
similarly to their counterparts crosslinked with glutaraldehyde. However, unlike 
glutaraldehyde, riboflavin is a non-cytotoxic crosslinking agent that is currently FDA 
approved for use in humans.170,176 In contrast, residual levels of most other crosslinking 
agents, such as glutaraldehyde, are cytotoxic. Lai et al. reported that the crosslinking of 
hAM with glutaraldehyde impacted their nanofibrous structures and negatively affected 
the culture of human corneal epithelial cells.173 
 
While our results characterize the properties of and demonstrate the potential of 
riboflavin-UVA crosslinked hAM, we have not yet tested this novel material for use in 
a particular regenerative medicine application. Each specific application will have a 
unique set of requirements, both chemical and physical that must be carefully assessed. 
Thanks to its enhanced mechanical properties and biodegradation rate, riboflavin-UVA 
crosslinked hAM would be a prime candidate for several clinical and tissue engineering 
applications. As a consequence of its attractive biological properties, transparency, 
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thinness, and composition akin to the one of the conjunctiva, the hAM has been widely 
used in ophthalmology for the treatment of a variety of ocular surface diseases.85,86 The 
hAM can be applied on the ocular surface either as a temporary dressing or as a 
permanent graft.38 When used as a temporary biological bandage, the hAM acts as 
barrier to protect the healing epithelium from the movement of the eyelids. However, 
hAM bandages degrade quickly and need to be replaced every week although repeated 
interventions at the diseased corneal surface are not recommended.38 With their 
increased biodegradation rate, riboflavin-UVA crosslinked hAM could be used as 
improved dressings for the healing corneal surface. 
Similarly, hAM degrade quickly when used as grafts for the transplantation of 
autologous limbal epithelial cells for the treatment of limbal stem cell deficiency.93 
Various crosslinking agents such as carbodiimide have been used to chemically 
crosslink the hAM and improve its biodegradation.62,67 These crosslinking techniques 
were effective at improving the mechanical properties of the scaffolds. However, the 
crosslinking agents used were highly cytotoxic, resulting in biocompatibility issues with 
the resulting scaffolds.171,174 
 
Thanks to its enhanced mechanical properties riboflavin-UVA crosslinked hAM would 
be a prime candidate for blood vessel tissue engineering,45 cartilage regeneration,46 
urothelium tissue engineering,47 and tendon repair.43 For instance, it has been reported 
in the literature that a native superior infraspinatus tendon has an elastic modulus of 32 
± 13 MPa and an ultimate tensile strength of 16.5 ± 7.1 MPa.198,199 Single or multilayer 
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constructs of riboflavin-UVA crosslinked hAM could be potentially used to generate 
tissue engineered tendons.43  
 
Conclusion 
In this study, we reported the successful application of riboflavin-UVA crosslinking to 
the hAM. Tissue samples exposed to riboflavin-UVA benefited from a 3-fold increase 
in mechanical properties and a decreased biodegradation rate while only incurring a 
minor decrease in glucose permeability. Moreover, riboflavin-UVA crosslinked 
membranes successfully supported the growth and differentiation of hASCs. Together 
these findings suggest that riboflavin-UVA crosslinking can be used to overcome the 
limitations of the hAM and broaden its use to new tissue engineering applications. 
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Chapter 4: Properties of Porcine Adipose-Derived Stem Cells and 
Their Applications in Preclinical Models 
 
Abstract 
Adipose-derived stem cells represent a reliable adult stem cell source thanks to their 
abundance, straightforward isolation, and broad differentiation abilities. Consequently, 
human adipose-derived stem cells (hASCs) have been used in vitro for several 
innovative cellular therapy and regenerative medicine applications. However, the 
translation of a novel technology from the lab to the clinic requires first to evaluate its 
safety, feasibility, and potential efficacy through preclinical studies in animals. The 
anatomy and physiology of pigs and humans are very similar, establishing pigs as an 
attractive and popular large animal model for preclinical studies. Knowledge of the 
properties of porcine adipose-derived stem cells (pASCs) used in preclinical studies is 
critical for their success. While hASCs have been extensively studied this past decade, 
only a handful of reports relate to pASCs. The aim of this chapter is to summarize the 
current findings about the isolation of pASCs, their culture, proliferation, and 
immunophenotype. The differentiation abilities of pASCs and their applications in 
porcine preclinical models will also be reported. 
 
Introduction 
Adipose-derived stem cells represent a reliable adult stem cell source thanks to their 
abundance, straightforward isolation, and broad differentiation abilities. Consequently, 
human adipose-derived stem cells (hASCs) have been used in vitro for several 
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innovative cellular therapy and regenerative medicine applications. However, the 
translation of a novel technology from the lab to the clinic requires first to evaluate its 
safety, feasibility, and potential efficacy through preclinical studies in animals. The 
anatomy and physiology of pigs and humans are very similar, establishing pigs as an 
attractive and popular large animal model for preclinical studies. Knowledge of the 
properties of porcine adipose-derived stem cells (pASCs) used in preclinical studies is 
critical for their success. While hASCs have been extensively studied this past decade, 
only a handful of reports relate to pASCs. The aim of this concise review is to 
summarize the current findings about the isolation of pASCs, their culture, proliferation, 
and immunophenotype. The differentiation abilities of pASCs and their applications in 
porcine preclinical models will also be reported. 
 
Isolation and Culture of pASCs 
Adult stem cells have been identified in several tissues and organs including peripheral 
blood, bone marrow, adipose tissue, skin, and skeletal muscle.200,201 Bone marrow 
mesenchymal stem cells have been the established standard for adult stem cells, but 
their harvest from bone marrow is a highly invasive procedure involving pain, 
morbidity and low cell yield.201 Adipose tissue has proven to be an attractive alternative 
cell source to bone marrow. 202,203 It has the advantage of being an abundant and easily 




The standard process highlighted in Figure 20 to isolate pASCs from adipose tissue is 
similar to protocols previously reported for hASCs. 204–206 The goal of this procedure is 
to isolate the stromal vascular fraction (SVF) containing the pASCs from the adipocytes 
by using simple physical treatments. The first step consists of obtaining adipose tissue 
from a pig biopsy. The most common locations for subcutaneous adipose tissue are the 
dorsal and abdominal areas. Other white adipose tissue sources can also be used to 
obtain pASCs. Niada et al. determined that the buccal fat pad, which is an encapsulated 
fat mass in the cheek, contains pASCs with comparable properties to cells harvested 
from the subcutaneous interscapular region207. After procurement, the adipose tissue is 
finely minced then digested (typically via collagenase type I treatment). Centrifugation 
and filtration with cell strainers separate adipocytes from the SVF containing the 
pASCs. After separation, adipocytes remain in the supernatant while the SVF pelletizes. 
The adipocytes are then discarded and the SVF pellet is resuspended in culture medium 
and seeded into culture flasks. Typical cell seeding densities range from 5000 to 7000 
cells/cm2.204,208,209 Dulbecco’s Modified Eagle Medium (DMEM) mixed 1:1 with 
Ham’s F-12 Nutrient Mixture and supplemented with 10% Fetal Bovine Serum has 
been reported as ideal for the culture of pASCs.204,209 After 48/72hrs in culture the non-
adherent hematopoietic cells are removed. The remaining adherent cells are pASCs who 
display an elongated morphology, similar to fibroblasts. These primary pASCs 
complete a cell cycle in 60 to 80 hours.204,210,211 Reports suggest that pASCs can reach 




Figure 20: Illustrations of the standard protocol used to isolate pASCs. 
Subcutaneous porcine adipose tissue is finely minced before being digested in a 
collagenase type I solution at 37°C. Centrifugation separates the supernatant 
containing adipocytes from the SVF pellet. Cells are then plated in a tissue culture 
flask. pASCs are adherent and adopt a fibroblast-like morphology in culture. 
 
 
On average, 0.5 to 1x106 viable and adherent pASCs are obtained per mL of adipose 
tissue.204,211 One parameter that has been shown to affect the recovery yield of pASCs is 
the age of the source animal from whom the cells are extracted.212,213 However, the 
abundance and accessibility of subcutaneous adipose tissue in pigs results in the ability 
to isolate several million cells from a single biopsy. Long term cryopreservation can 
also be used to store pASCs indefinitely. Cryopreserved pASCs have been shown to 
display similar proliferative characteristics, expression of cell surface markers, and 
differentiation abilities to fresh pASCs.214  
 
Immunophenotype of pASCs 
hASCs have been thoroughly characterized with an extensive literature available 
detailing their isolation, proliferation, immunophenotype, and differentiation abilities. 
The International Federation for Adipose Therapeutics and Science (IFATS) and the 
International Society for Cellular Therapy (ISCT) have defined phenotypic and 
functional criteria to identify hASCs.215 Currently, no criteria have been established to 
facilitate the identification of porcine stem cells, either bone marrow or adipose derived. 
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Characterization of these animal cells is largely based on morphologic, phenotypic and 
functional properties, and can still appear rather ambiguous.  
 
Flow cytometry is a convenient and fast method to analyze the immunophenotype of a 
cell population. It is a powerful tool routinely used to assess the characteristics of a 
freshly isolated population of cells and verify that they have not been contaminated with 
endothelial or hematopoietic cells. Indeed, the SVF can include cells other than adipose 
stem cells such as blood cells, smooth muscle cells, fibroblasts, and endothelial cells.  
Fluorescence-activated cell sorting (FACS) can be used to purify a cell population by 
removing undesired subpopulations. Protocols have also been established with hASCs 
to isolate specific subpopulations of progenitor cells among the hASCs population.200,202 
Similar strategies haven’t been implemented on pASCs yet but could prove beneficial 
for future studies.  
 
Flow cytometry analysis of some pASCs surface markers can prove challenging. Many 
porcine surface antigens are not cross-reactive with antibodies designed for other 
species and require porcine-specific antibodies. For instance, among the seven porcine 
surface antigens reported in Table 1, only CD44, CD90, and CD105 are cross-reacting 
with anti-human antibodies. A limited number of porcine-specific antibodies are 
currently commercially available. Consequently, published studies were consistent with 
one another and reported the use of similar antibodies. The expression of several cell 
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CD105 + 216,218 + 200,202,203 
 
Table 1: Expression of cell surface markers for pASCs and hASCs determined by 
flow cytometry analysis for cells cultured at low passage numbers and in regular 
FBS supplemented culture medium. “+” corresponds to a positive expression of 
the cell surface marker, “–” for a low or non-expressed cell surface antigen. 
 
CD29, CD44, CD90 and CD105 are part of the typical panel of surface markers 
characteristic of mesenchymal stem cells. These markers are positively expressed by 
pASCs, demonstrating their stemness. Analysis of stem cell transcription factors (Oct-4, 
Sox-2, and Nanog) by RT-PCR also reveals that pASCs express these markers of 
primitive stem cells.219 
pASCs do not express hematopoietic stem cell markers CD14 and CD45, nor do they 
express CD31 which is a marker characteristic of endothelial cells. Measuring the 
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expression of CD14, CD45, and CD31 after isolating a new population of pASCs is a 
useful technique to verify that the stem cell population is not contaminated with 
endothelial or hematopoietic cells. 
 
Overall, the cell surface marker expression profile for these typical markers appears 
similar between pASCs and hASCs. However, the few antibodies available for pASCs 
only provide a limited representation of the expression of surface antigens by pASCs. 
 
Multilineage differentiation abilities 
Besides self-renewal, a high proliferative capacity, and the expression of specific cell 
surface markers, another defining characteristic of a stem cell is its ability to 
differentiate into multiple lineages.200,215 hASCs have demonstrated the ability to 
differentiate into multiple cell types such as osteoblasts, chondrocytes, adipocytes, 
epithelial cells, endothelial cells, smooth muscle cells, neural cells, and 
hepatocytes.200,201,220 While the differentiation abilities of hASCs have been extensively 
studied this past decade, only a handful of reports have been related to pASCs. Figure 
21 illustrates the differentiation pathways previously reported with pASCs along with 




Figure 21: Multilineage differentiation abilities of pASCs. Major typical reagents 
are specified for each pathway. pASCs have been shown to be able to differentiate 
into adipocytes, osteoblasts, chondrocytes, hepatocytes, and neurons, as well as 
being able to be reprogrammed into induced pluripotent stem cells. 
 
The adipogenic, osteogenic and chondrogenic differentiation are classic and easily 
obtainable mesodermal lineages differentiation pathways. Differentiation protocols for 
these three lineages are well established, and have been reported with pASCs.208,221,222 
However, studies related to ectodermal or endodermal lineages are scarce. Currently, it 
has been reported that pASCs can transdifferentiate into hepatocytes,216,223 
neurons,210,224 and pancreatic islet-like clusters.225 Using lentivirals carrying 
reprogramming factors, pASCs have also been reprogrammed into induced pluripotent 
stem cells (iPSCs).218,226 Song et al. also described that pASCs could also differentiate 
into oocyte-like cells.219 
pASCs have been shown to demonstrate similar characteristics to other porcine-derived 
adult stem cells such as those derived from bone marrow, peripheral blood, adipose 
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tissue, synovial membrane, and skin.206,227,228 These include comparable morphology, 
proliferative capacity, alkaline phosphatase activity, cell surface marker expression, 
metabolic pathways, biological functions, and transcription factors.209,222,229 pASCs 
have often been compared side-by-side with porcine stem cells from these other tissue 
sources, revealing characteristics and comparable multilineage differentiation abilities 
as well. 208,222,227  
 
While knowledge of the differentiation abilities of pASCs is currently limited to a few 
reports, porcine bone marrow-derived stem cells (pBMSCs) have been differentiated 
into myocytes,230 endothelial cells,231 and epithelial cells.232 Since pBMSCs and pASCs 
characteristics are very similar,233 it can be assumed that these differentiation pathways 
reported for pBMSCs should also apply to pASCs. 
 
Applications in Preclinical Models 
Adult stem cells have proven to be effective for the treatment of several diseases and 
the repair and regeneration of damaged tissues in vitro.200,202,228 Preclinical animal 
studies represent a critical step in the translation of a cell transplantation or tissue 
engineering technology from the lab to the clinic. They are required to evaluate the 
safety, feasibility and potential efficacy of novel therapies.201,208 Two criteria need to be 
addressed in order for an animal study assessing a novel cell-based approach to be 
beneficial. The animal chosen for the study has to mimic human physiology as closely 
as possible, and the animal cells that are being used need to be precisely identified and 
characterized. Some previous clinical trials did not adhere to these guidelines and 
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concluded with unsatisfactory results. One shortcoming often comes from the use of 
rodents whose physiology and organ size does not properly match that of humans. 234 
Results obtained with small animals, whose anatomy is different to humans, do not 
typically extrapolate properly to human clinical trials.208 Large animals such as pigs 
represent a preferable model. Their organ size along with cell number and distribution 
more closely mimic human characteristics. Pigs are some of the most attractive and 
relevant large animal models for preclinical studies since their size, anatomy, genomic 
organization, and physiology are very similar to humans.206,208,235 In a porcine 
preclinical model, the autologous transplantation of pASCs avoids triggering an adverse 
immune response. 
 
Pigs have been used to investigate innovative pASCs bone regeneration strategies.235 
The osteogenic differentiation of pASCs is a well-known process.222,236,237 Several 
studies combined pASCs differentiated into osteocytes with various types of scaffold 
such as hydroxyapatite,221 polycaprolactone,238 or oligo (polyethylene glycol) fumarate 
(OPF) hydrogel239 to repair osteochondral defects. pASCs have also been implanted in 
pigs to evaluate their therapeutic effect in the treatment of osteonecrosis of the femoral 
head240 and for the regeneration of osteochondral defects.241,242 Pigs have also proven a 
suitable model for oral and maxillofacial studies.207,243 Wilson et al. demonstrated that 
injections of pASCs enhanced healing of mandibular defects in pigs.244 
 
The vascular anatomy and physiology of pigs are quite similar to humans. Pigs have 
consequently been broadly used to evaluate novel vascular therapies.245 Recent studies 
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include the intracoronary administration of pASCs after an acute myocardial infarction 
model246–248 and the transplantation of pASCs cell sheets in a porcine model of chronic 
heart failure.249 
 
The structures of porcine and human skin are similar, making pigs a suitable model for 
dermatologic preclinical studies. Hanson et al. harvested pASCs and pBMSCs and 
injected them in a dermal wound model to study the feasibility of stem cells injections 




pASCs express cell surface markers characteristic of mesenchymal stem cells and are 
able to differentiate into several lineages. Knowledge about the possible 
transdifferentiation abilities of pASCs is currently limited but will expand in the 
foreseeable future. The development of standard protocols for the isolation, culture and 
differentiation of pASCs would further improve pASC-based preclinical studies.250  
 
Pigs represent an excellent animal model for preclinical studies. Besides their similar 
morphology and physiology to humans, they also have the advantage of providing large 
quantities of easily obtainable subcutaneous tissue, resulting in a generous supply of 
pASCs. 
Miniature pigs are being developed with the goal to increase the efficiency and 
translation of preclinical studies in pigs. Minipigs have the advantage of slower growth 
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curves and a similar weight to an average human male, between 150 to 200lbs.239,251,252 
Such a new advantageous animal model has the potential to become increasingly 










The mechanical properties of soft materials are critically important for a wide range of 
applications ranging from packaging to biomedical purposes. We have constructed a 
simple mechanical testing apparatus using off-the-shelf materials and open-source 
software for a total cost of less than $100. The device consists of a wooden frame 
supporting a central loading apparatus attached via drawer slides. To perform a 
mechanical test, a sample was secured within two custom-made 3D-printed clamps 
affixed to brackets on the base of the frame and the load cell. The extension force was 
applied by the user pulling on a rope, moving the central loading apparatus up (thereby 
stretching the sample) while recording the force (measured by a load cell) and the 
displacement (measured by an ultrasonic sensor). The load cell and ultrasonic sensor 
were linked to an Arduino microcontroller connected to a laptop through a USB port for 
data acquisition and analysis. This instrument was easy to assemble and enabled 
students to better grasp the meaning of tensile testing while promoting experimentation 
with electronics, computer programming and mechanical design. Due to its low cost and 
ease of use, this Arduino-based uniaxial tensile tester can be an ideal device to 






Figure 22: Example of a nitrile glove being tested and stretched in the Arduino-
based mechanical tester. 
 
Introduction 
The mechanical properties of a material relate to how it responds to mechanical stress. 
These properties are critical in determining a material’s suitability for potential 
applications. Uniaxial tensile testing is the most common procedure used to measure 
these mechanical properties, which include the Young’s modulus, yield strength, and 
ultimate tensile strength, among others. Commercial tensile testers are highly accurate 
but their cost and size make them impractical for hands-on-learning in a classroom 
setting.253 Furthermore, they often require costly proprietary software to operate with 
restrictive software licensing agreements. Recently, open-source electronics have been 
used to build hardware/software systems that are yet not commercially available or 
otherwise too expensive.254 Among them, the popular Arduino microcontroller has 
already proven effective in controlling scientific hardware for research purposes255–259 
while also serving as a practical platform for the training of students.260,261 Previous 
educational applications of the Arduino platform include the fabrication of a 
photometer262, an automatic titrator263, a pH meter264, a gas sensor265, an electronic 
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buret266, and a potentiostat.267 Our objective was to develop an inexpensive and portable 
mechanical tester that could be used for both accurate measuring and educational 
purposes. Due to its flexibility, low cost, ease-of-use, and wide range of successful 
applications, we decided to use an Arduino microcontroller to develop our tester, 
combining it with simple off-the-shelf components. 
 
Materials and Methods 
The mechanical tester consists of a wooden frame with a central loading apparatus 
attached via drawer slides to allow for uniaxial translation, provided by a rope and 
pulley system (via manual application of force to the rope by the user). The central 
loading apparatus consists of a wooden block with a rope attachment point on top with a 
mounting bracket for the load cell on the bottom. Sample holding clamps with 
symmetric interlocking teeth were designed and 3D printed (STL file available in the 
supporting information). The clamps were attached to both the frame and the load cell 
via mounting brackets with clevis pins as shown in Figure 23. 
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Figure 23: Several different views of the mechanical tester. The front view, A, 
shows the overall assembly of the tester comprising a wooden frame, a rope-and-
pulley system, a central loading apparatus with attached load cell, two sample 
clamps (black), and the electronics (left). The side views, B and C, reveal the 
circuitry consisting of a bread board (white), an Arduino Uno (in blue case), and 
the USB interface for connection to a computer. The back views, D and E, reveal 
the placement and design of the ultrasonic proximity sensor (in red case), with 
attached leads. More detail on the circuitry can be seen in Figure 24. More 
information on the materials is present in the supporting information. 
 
In order to determine the mechanical properties of a sample, two parameters need to be 
recorded: the load applied to the sample and its extension. In order to measure the load, 
a 5 kg micro load cell (combined with an INA125P amplifier) was placed in series with 
the sample (prior to sample runs the load cell circuit was calibrated via a linear 2-point 
calibration spanning the sampling range). The extension was measured with an HC-
SR04 ultrasonic sensor that measured the distance between the frame and the central 
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loading apparatus to which the load cell (and upper sample clamp) were attached. This 
sensor works by emitting an ultrasonic pulse which reflects off of the central loading 
apparatus and is subsequently read by the sensor; the time interval between the signal 
emission and detection is used to calculate the distance. Both sensors were connected to 
the Arduino Uno microcontroller as shown in Figure 24. 
 
 
Figure 24: The wiring configuration for the 5 kg load cell (gray, top, silver bracket 
in Figure 22) and the ultrasonic proximity sensor (blue, top, depicted within red 
enclosure in Figure 22) connected to the Arduino Uno microcontroller (blue, 
bottom-right, blue enclosure in Figure 22). A breadboard was used to connect 
these components with the addition of a 100 Ω resistor and an INA125P signal 
amplification chip. More information on the wiring is available in the supporting 
information. Created with Fritzing 0.9.3b. 
The Arduino Uno was connected via a USB interface to a laptop running the Arduino 
Integrated Development Environment (IDE). Values were recorded every 100 ms 
during a sample run and subsequently exported to Microsoft Excel for processing. 
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Results and Discussion 
The total material cost to build this mechanical tester was under $100 (bill of materials 
available in the supporting information). This apparatus was lightweight and compact, 
rendering it readily portable. The inexpensive, off-the-shelf load cell and ultrasonic 
sensor resulted in accurate and precise measurements. The resulting mechanical 
properties determined with our Arduino-based mechanical tester were comparable to 
those obtained with a commercial United SSTM-2 tensile tester as shown in Figure 25 
and Table 2.  
 
A stress-strain curve represents the behavior of a material during mechanical testing. 
Stress is defined as the force applied divided by the area. For a tensile test, the relevant 
area is that perpendicular to the applied force (in this case the cross-sectional area). 
Strain describes the elongation with respect to the initial length of the sample. The 
ultimate tensile strength represents the maximum stress that a material can withstand 
before breaking. The Young’s modulus or elastic modulus of a material is defined as the 
slope of its stress-strain curve in the region of elastic deformation. Representative 
stress-strain curves for latex glove samples obtained from both the Arduino-based 
mechanical tester and the commercial uniaxial tensile tester (United Smart Table 




Figure 25: A side-by-side comparison of the Arduino-based tester developed herein 
(blue curve) and the commercial grade tester (red curve; UNITED SSTM-2) for 
samples cut from a latex glove. Stress (on the ordinate axis) is the force F (as 
measured by the load cell) divided by the cross-sectional area Ac of the sample 
(calculated as the thickness of the sample times its width); strain (on the abscissa) 
is the amount of elongation with respect to the original length L0 of the sample. 
From this graph the Ultimate Tensile Strength (UTS) is the maximum stress 
obtained prior to failure, and the Young’s Modulus is calculated by fitting a 
straight line to the initial part of the tensile curve (tangent modulus determined in 
the linear elastic region). 
 
Several household and common laboratory items were used as samples for mechanical 
testing. Each sample was stretched until failure, and the resulting Young’s modulus and 
ultimate tensile strength values are reported in Table 2. Samples were selected such that 
they would provide qualitative feedback for students during a sample run; this was 
accomplished by selecting samples with high strain rates at failure (so the student could 
witness a large degree of stretching) and fairly high, though obtainable, ultimate tensile 
strengths (so the student could feel the increasing force required to continue stretching 
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the sample until failure). All the samples tested were prepared with the same 




Young's Modulusc Ultimate Tensile Strengthc 
Arduino Commercial Arduino Commercial 
Latex Glove 110 µm 730 ± 10 kPa 740 ± 10 kPa 3.2 ± 0.1 MPa 3.3 ± 0.1 MPa 
Nitrile Glove 70 µm 2.3 ± 0.3 MPa 2.4 ± 0.2 MPa 4.4 ± 0.1 MPa 4.4 ± 0.1 MPa 
Parafilm 130 µm 52 ± 5 MPa 57 ± 7 MPa 2.4 ± 0.2 MPa 2.4 ± 0.1 MPa 
Biohazard 
Bag 70 µm 133 ± 6 MPa 135 ± 5 MPa 11.8 ± 0.1 MPa 11.6 ± 0.1 MPa 
Trash Bag 40 µm 55 ± 4 MPa 52 ± 3 MPa 8.4 ± 0.1 MPa 8.2 ± 0.2 MPa 
Gauze 300 µm 1.2 ± 0.1 MPa 1.4 ± 0.2 MPa 5.9 ± 0.3 MPa 6.1 ± 0.2 MPa 
aAll samples were cut to 20x65 mm rectangles, clamped such that ~30 mm of sample was 
available for testing (i.e. between the clamps). As is evident, the Arduino-based tester values are 
in excellent agreement with those for the commercial grade tester. Furthermore, the error in each 
value is quite low due to the commercial production (and regulation) of each of the materials 
tested. 
bMaterial thickness was measured with a digital caliper. 
c(n=3 for each; values presented as mean ± SD). 
Table 2: Mechanical property value comparison for tested samples. 
 
Mechanical testing allowed us to illustrate the differences among mechanical behaviors. 
After applying some stress to them, nitrile and latex gloves return to their initial 
dimensions thereby characterizing their deformation as elastic, reversible and non-
permanent. For the trash and biohazard bags, however, there was observed a permanent 
and irreversible plastic deformation. Being able to characterize such deformations 
distinctly demonstrates the wide applicability of this device to a broad range of 
materials, and thus a wide range of fields and disciplines.253,268 
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We believe that this mechanical tester is an ideal tool for project-based learning. We 
tested six different materials in order to determine the differences among them, and 
validate the device. Many different samples could be tested by students, and their 
resulting values could be compared with reference values reported in this or other 
sources (of special interest could be the comparison of material properties with standard 
specifications such as ISO and ANSI). Students could also be asked to produce a 
composite material and try to match some target mechanical properties by altering its 
layers and composition. Having students replicate tests of the same type of sample 
could also be used as an introduction to some basic statistics concepts. 
 
Furthermore, building this mechanical tester could be defined as a group project for 
upper-division undergraduate students. The Arduino IDE is downloadable for free 
online, and the Arduino programming language is simple and intuitive. Other resources 
are available to automate and visualize the process of data collection, such as the Excel 
spreadsheet PLX-DAQ .269 Implementation of such open-source electronics in a 
curriculum has been shown to develop complementary skills for the students as well as 
bringing an extra element of interactively engaging students.270,271  
 
This mechanical tester could easily be modified for a variety of different tests. The 5kg 
micro load cell could be replaced to adjust the reading range of the device (from 0.5 kg 
to 20+ kg) in order to better accommodate various samples. Standards weights or a 
bucket progressively filled with water would allow to control more precisely the force 
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applied to the sample. A stepper motor could be used instead of the rope and pulley 
mechanism, in order to provide a constant strain rate (though this would increase the 
cost of the device). Finally, this mechanical tester could also be modified for 
compression testing instead of stretching. 
 
One final advantage of this device is that all the parts and sensors used could easily be 
reused for other projects. The Arduino microcontroller has already been used for 
different applications as described earlier. It is possible to imagine that the same 
Arduino microcontroller could be used for several active learning class activities 
throughout a semester. 
 
Conclusion 
We described the fabrication of an easy-to-use uniaxial tensile tester for a total cost of 
less than $100. The simplicity and flexibility of the Arduino platform suggests that this 
is a practical, accurate system for hands-on demonstrations for the determination of the 
mechanical properties of several different materials. The experiments detailed herein, 
which can be applied to a wide variety of disciplines, were performed with household 
and common laboratory items as samples. These revealed the accuracy of the system (as 
compared with an industrial mechanical tester) and allowed for reliable determination 
of material properties. Though not intended as a replacement for truly quantitative 
experimentation, this device serves as an ideal platform for hands-on learning as its 
construction and use encompasses several disciplines and it lends itself to numerous 
potential modifications for expansion to further applications.
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Chapter 6: Conclusions and Future Directions 
 
The hAM is a readily available and inexpensive biomaterial that can efficiently be 
processed, preserved, and de-epithelialized. Decellularized hAM has proven worthwhile 
for a broad range of tissue engineering applications due to its ability to support cell 
attachment, proliferation, and differentiation. Modifications of the hAM have been 
developed to tune its properties, either through composite materials incorporating the 
hAM, chemical crosslinking, or innovative layering and tissue preparation strategies. 
Overall, the hAM is truly a versatile biomaterial and its foreseeable future as a scaffold 
for tissue engineering applications looks very promising. The development of standard 
processing protocols and tissue banks, along with commercially available hAM derived 
products, will further expand the clinical applications of the hAM. 
 
In Chapter 3 was reported the successful application of riboflavin-UVA crosslinking to 
the hAM. Tissue samples exposed to riboflavin-UVA benefited from a 2.5-fold increase 
in mechanical properties and a decreased biodegradation rate while only incurring a 
minor decrease in glucose permeability. Moreover, riboflavin-UVA crosslinked 
amniotic membranes successfully supported the growth and differentiation of human 
adipose-derived stem cells. Together these findings suggest that riboflavin-UVA 
crosslinking can be used to overcome the limitations of the hAM and broaden its use to 
new tissue engineering applications. While our results characterize the properties of and 
demonstrate the potential of riboflavin-UVA crosslinked hAM, we have not yet tested 
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this novel material for use in a particular regenerative medicine application. Each 
specific application will have a unique set of requirements, both chemical and physical 
that must be carefully assessed. Thanks to its enhanced mechanical properties and 
biodegradation rate, riboflavin-UVA crosslinked hAM would be a prime candidate for 
blood vessel tissue engineering, cartilage regeneration, urothelium tissue engineering, 
and tendon repair.  
 
Chapter 4 summarized the current findings about the isolation of porcine adipose-
derived stem cells (pASCs), their culture, proliferation, and immunophenotype. The 
differentiation abilities of pASCs and their applications in porcine preclinical models 
was also reported. pASCs express cell surface markers characteristic of mesenchymal 
stem cells and are able to differentiate into several lineages. Knowledge about the 
possible transdifferentiation abilities of pASCs is currently limited but will expand in 
the foreseeable future. The development of standard protocols for the isolation, culture 
and differentiation of pASCs would further improve pASC-based preclinical studies.  
 
In Chapter 5 was described the fabrication of an easy-to-use uniaxial tensile tester for a 
total cost of less than $100. The simplicity and flexibility of the Arduino platform 
suggests that this is a practical, accurate system for hands-on demonstrations for the 
determination of the mechanical properties of several different materials. The 
experiments detailed herein, which can be applied to a wide variety of disciplines, were 
performed with household and common laboratory items as samples. These revealed the 
accuracy of the system (as compared with an industrial mechanical tester) and allowed 
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for reliable determination of material properties. Though not intended as a replacement 
for truly quantitative experimentation, this device serves as an ideal platform for hands-
on learning as its construction and use encompasses several disciplines and it lends 
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Appendix A: Uniaxial Tensile Testing of Human Amniotic Membranes 
 
This appendix contains supplementary data to Chapter 03 “Characterization of 
Riboflavin-UVA Crosslinking of Amniotic Membranes and its Influence on the Culture 
of Adipose-Derived Stem Cells”. 
A stress-strain curve represents the behavior of a material during mechanical testing. 
Stress is defined as the force applied divided by the area. For a tensile test, the relevant 
area is that perpendicular to the applied force (in this case the cross-sectional area). 
Strain describes the elongation with respect to the initial length of the sample. The 
ultimate tensile strength represents the maximum stress that a material can withstand 
before breaking. The Young’s modulus or elastic modulus of a material is defined as the 
slope of its stress-strain curve in the region of elastic deformation. 
For the uniaxial tensile testing of human amniotic membranes, sample gauge length was 
30 mm and width was 20 mm. The thickness of the human amniotic membrane changes 
depending on its hydration state and is consequently very hard to measure. For all 
samples, the thickness of the human amniotic membrane was set constant at 50 µm. 
After decellularization, all tissue samples possessed a uniform thickness. This value of 
50 µm was measured on histological pictures of decellularized human amniotic 
membranes. For testing, each sample was mounted between two pneumatic grips and 
preloaded to 5 g of force for 10 seconds before being stretched until failure at a 



















Figure 26: Typical stress-strain curve for a noncrosslinked hAM sample. 
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Appendix B: Long Term Riboflavin-UVA Exposure for Human 
Amniotic Membrane Crosslinking 
 
This appendix contains supplementary data to Chapter 03 “Characterization of 
Riboflavin-UVA Crosslinking of Amniotic Membranes and its Influence on the Culture 
of Adipose-Derived Stem Cells”. 
 
For the experiments reported in Chapter 03, human amniotic membranes were exposed 
to riboflavin at various concentrations but for a constant 60min reaction time. In this 
appendix, results are reported for crosslinking of the human amniotic membrane with 
various concentrations of riboflavin but also exposure times ranging from 30min to 24 
hours. 
 
Decellularized amniotic membranes were submerged in solutions of riboflavin (Sigma-
Aldrich) at different concentrations and exposed to UV light at 366 nm on a 
transilluminator (Fotodyne, Hartland, WI) with an intensity of 4mW/cm2. Exposure 
time to the UV light ranged from 30 min to 24 hours and concentrations of riboflavin 
ranged from 0.001 to 0.1 g/L. As a control, some amniotic membranes were also 
crosslinked in a 10mM solution of glutaraldehyde for similar exposure times. All 
crosslinked samples were thoroughly washed with phosphate buffered saline to remove 




Control experiments of UV irradiation without riboflavin of noncrosslinked hAM were 
performed for exposure times of 30, 60, 120 min. Without any exposure to UV 
irradiation, noncrosslinked hAM had a Young’s modulus of 4.8 ± 0.6 MPa and an 
ultimate tensile strength of 1.06 ± 0.08 MPa. (see data on Figure 10). Noncrosslinked 
hAM exposed to UV irradiation without riboflavin for 30, 60, and 120min displayed 
Young’s modulus of 4.6 ± 0.9 MPa, 5.2 ± 0.8 MPa, 4.9 ± 0.5 MPa and ultimate tensile 
strengths of 1.01 ± 0.05 MPa, 1.11 ± 0.12 MPa, and 1.04 ± 0.08 MPa respectively. It 




Figure 27: Chemical reaction of riboflavin with the collagen fibers of the human 




Figure 28: Chemical reaction of glutaraldehyde with the collagen fibers of the 
































Figure 29: Crosslinking degrees determined by ninhydrin assay of hAM exposed to 
UVA-riboflavin or glutaraldehyde crosslinking as compared to noncrosslinked 




































Figure 30: Young’s Modulus of noncrosslinked hAM and hAM crosslinked with 







































Figure 31: Ultimate Tensile Strength of noncrosslinked hAM and hAM crosslinked 




































Figure 32: Crosslinking degrees determined by ninhydrin assay of hAM exposed to 
UVA-riboflavin at a medium concentration of 0.01 g/L as compared to 



































Figure 33: Young’s Modulus of noncrosslinked hAM and hAM crosslinked with a 








































Figure 34: Ultimate Tensile Strength of noncrosslinked hAM and hAM crosslinked 
with a medium concentration (0.01g/L) of riboflavin for reaction times of 0.5, 1, 2, 
12 and 24 hours. 
121 
Appendix C: Permeability Measurement 
 
This appendix contains supplementary data to Chapter 03 “Characterization of 
Riboflavin-UVA Crosslinking of Amniotic Membranes and its Influence on the Culture 
of Adipose-Derived Stem Cells”. 
 
Experimental setup 
A side-by side diffusion chamber was designed to allow the measurement of the 
effective diffusivity through the human amniotic membrane. The setup consists of two 
cylindrical chambers having a diameter of 9.5 mm, a length of 3.5 cm, and an individual 
volume of 2.5 ml. Before being placed in the diffusion chamber, the decellularized 
hAM was dissected into squares sections having a side length of approximately 1.5 cm. 
 
Figure 35: Cross sectional view and side view of the custom-made diffusion 
chambers. 
 
Glucose was chosen for the diffusion measurements because it is a key component in 
cell culture media and necessary for cell nutrition and survival. Glucose was loaded on 
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one side of the chamber at a concentration of 1 mg/mL and DI water was used to fill the 
second side. 10 µL samples from both sides were taken every 15min during 2 hours. 
 
Glucose Enzymatic Assay 
Glucose concentrations were computed using an enzymatic method that results in an 
increase in the absorbance of the samples which is proportional to the glucose 
concentration. Standards of known glucose concentrations were prepared (0, 0.2, 0.4, 
0.6, 0.8 and 1 mg/ml). Samples and standards were assayed in triplicate to account for 
sampling error. 10 µl of sample or standard was added to each well. Each occupied well 
was then supplemented with 100 µl of glucose assay reagent (G3293, Sigma). Blanks 
were prepared for each sample, in which 100 µl of DI water replaced the glucose assay 
reagent. The 96-well plate was incubated on a shaker for 20 minutes allowing the 
glucose assay reagent to react with the samples.  
Finally, the absorbance was measured at 340 nm (Bio-Tek, Winooski, VT). Using the 
data from the standards a linear relationship between the absorbance measured and the 
glucose concentration was determined. The glucose concentrations in the assayed 
samples were then determined by linear regression analysis of the standard curve.  
 
Permeability of the Human Amniotic Membrane 
Concentrations of glucose at each time point were calculated by measuring the 
absorbance of the sample as illustrated in the previous section. To calculate its 
coefficient of diffusion, the human amniotic membrane was considered as a thin 
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membrane and a quasi-steady state was assumed. The following equation was used to 






Using this expression, it was possible to plot the value of 




in a linear fit with a slope of 
- "#$%&''()*$   
. Consequently, the apparent diffusion 
coefficient was calculated as: 






• C0 is the initial solute concentration in chamber 1. 
• C1 is the measured solute concentration in chamber 2 at t time. 
• Am is the cross-sectional area of the amniotic membrane (0.713cm2). 
• Lm is the thickness of the amniotic membrane (50 µm). 
• V is the volume of each chamber (2.50 ml). 
The permeability P of glucose to the membrane was deduced from the apparent 





Appendix D: Flow Cytometry Analysis 
 
This appendix contains supplementary data to Chapter 03 “Characterization of 
Riboflavin-UVA Crosslinking of Amniotic Membranes and its Influence on the Culture 
of Adipose-Derived Stem Cells”. 
 
 
Description Fluorochrome Isotype Size Company Product	Number
anti-CD29 PE Ms	IgG1 ,	κ 25	Tests BD	Biosciences 561795
anti-CD34 FITC Ms	IgG1 ,	κ 25	Tests BD	Biosciences 560942
anti-CD44 PE Ms	IgG1 ,	κ 100	Tests BD	Biosciences 550989
anti-CD45 PE Ms	IgG1 ,	κ 25	Tests BD	Biosciences 560975
anti-CD73 PE Ms	IgG1 ,	κ 25	Tests BD	Biosciences 561014
anti-CD90 FITC Ms	IgG1 ,	κ 0.1mg BD	Biosciences 555595
anti-CD105 FITC Ms	IgG1 ,	κ 100	Tests BD	Biosciences 561443
Ms	IgG1 ,	κ	Isotype	control PE Ms	IgG1 ,	κ 100	Tests BD	Biosciences 555749
Ms	IgG1 ,	κ	Isotype	control FITC Ms	IgG1 ,	κ 100	Tests BD	Biosciences 555748
Stain	Buffer	FBS 500mL BD	Biosciences 554656  




Appendix E: Supporting Information for the 
Fabrication of an Economical Arduino-Based Uniaxial Tensile Tester 
 
Bill of materials 
Item Supplier Product	Number Price
Wood Home	Depot 2x4	/	2x6	/	4x4 10.00$			 	
Drawer	Slide McMaster-Carr 11435A12 9.00$					 	
Arduino RobotShop RB-Ard-34 23.00$			 	
Load	Cell RobotShop RB-Phi-118 7.00$					 	
Ultrasonic	Sensor Amazon HC-SR04 3.00$					 	
INA125P eBay INA125P 5.00$					 	
Breadbord	&	Jumper	Wires Amazon Misc. 6.00$					 	
Brackets	&	Clevis	Pin McMaster-Carr 1755A52 7.00$					 	
Rope McMaster-Carr 2222T46 8.00$					 	
Miscellaneous	hardware	
(screws,	bolts,	nuts	etc.)
Various Misc. 10.00$			 	
Total 88.00$			 	  
Table 4: Bill of materials for the Arduino-based mechanical tester. 
 
A majority of the parts used to build the mechanical tester prototype were recycled from 
previous projects, hence the estimated rounded prices for the parts. 
 
Polymer or metal components could also be used instead of wood to build the 
mechanical tester frame. This would result in a better looking but also heavier and more 
expensive device. Wood presents the advantages of being inexpensive, structurally very 




Mechanical Tester Assembly 
Two 12x12x2 square pieces of pressured treated wood were used for the base and top 
parts of the mechanical tester. The sides consisted of two 40x6x2 pieces of wood. These 
parts were attached together to form the frame of the mechanical tester using wood glue 
and 3” long wood screws. The drawer slide was attached to the inside of the pillars 
using the provided hardware. A 10x4x4 piece of wood was connected to the drawer 
slide and used as the central loading apparatus were the load cell was attached. The rope 
used was 5ft long, made of high-performance polyester (Vectran) and designed 
specifically for lifting with low-stretch. It was attached to the central piece through a 
bracket and traveling through a pulley mounted under the top square piece of the frame. 
A set of brackets to mount sample clamps were attached to the load cell and the bottom 
of the frame. Electronics and wires were secured at the back of the mechanical testing in 
order to not interfere during mechanical testing. 
 
Wiring Details 
   
Figure 36: Wiring details for the Arduino-based mechanical tester. 
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For the 5 kg load cell: 
• Black wire: Excitation - 
• Green wire: Signal + 
• White wire: Signal - 
• Red wire: Excitation + 
 
For the INA125P amplifier: 
• 100 Ω resistor connected between pins 1 and 16 
• Yellow wire between pins 2 and 3 
• Blue wire between pin 3 and Arduino Analog Input A0 
• Black wire between pin 4 and ground 
• Yellow wire between pins 7 and 12 
• Yellow wire between pins 9 and 10 
• Black wire from load cell on pin 13 
• Red wire from load cell on pin 10 
• Green wire from load cell on pin 14 
• White wire from load cell on pin 15. 
 
For the HC-SR04 ultrasonic sensor: 
• Red wire: VCC, to 5V. 
• Green wire: Trig, to Arduino digital input 2 
• Blue wire: Echo, to Arduino digital input 4 
• Yellow wire: GND, to ground. 
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Sample Holding Clamps 
 
Figure 37: Sample holding clamps for the Arduino-based mechanical tester. 
 
These sample holding clamps have symmetric interlocking teeth and are attached 
together with bolts and wingnuts. They were 3D printed in polylactic acid (PLA) on a 
Makerbot Replicator 5th generation. They were 100mm wide by 60mm tall and 5mm 









// 5kg load cell calibration 
// Weight of item A in grams 
float loadA = 68.83;  
// Analog reading taken with item A 
int analogvalA = 50;  
// Weight of item B in grams 
float loadB = 1050.62;  
// Analog reading taken with item B 
int analogvalB = 183;  
float analogValueAverage = 0; 
long time = 0; 
int timeBetweenReadings = 100; 
// Trig Pin of the HC-SR04 on input 02 
int trigPin = 2;  
// Echo Pin of the HC-SR04 on input 04 
int echoPin = 4; 
void setup() { 
  Serial.begin(9600); 
} 
void loop() { 
// Load cell on Analog input A0 
  int analogValue = analogRead(0); 
  analogValueAverage = 0.99*analogValueAverage + 0.01*analogValue; 
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  if(millis() > time + timeBetweenReadings){ 
    float load = analogToLoad(analogValueAverage); 
    Serial.print("analogValue: ");Serial.println(analogValueAverage); 
    Serial.print("             load: ");Serial.println(load,2); 
    time = millis(); 
      long duration; 
  float cm; 
  pinMode(echoPin, INPUT); 
  pinMode(trigPin, OUTPUT); 
  digitalWrite(trigPin, LOW); 
  delayMicroseconds(2); 
  digitalWrite(trigPin, HIGH); 
  delayMicroseconds(10); 
  digitalWrite(trigPin, LOW); 
  duration = pulseIn(echoPin, HIGH); 
  cm = microsecondsToCentimeters(duration); 
  Serial.print(cm); 
  Serial.print("cm"); 
  Serial.println(); 
  delay(10); 
  } 
} 
float analogToLoad(float analogval){ 
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  float load = mapfloat(analogval, analogvalA, analogvalB, loadA, loadB); 
  return load; 
} 
float mapfloat(float x, float in_min, float in_max, float out_min, float out_max) 
{ 
  return (x - in_min) * (out_max - out_min) / (in_max - in_min) + out_min; 
} 
float microsecondsToCentimeters(long microseconds){ 
  return (microseconds*0.034029)/2; 
} 
 
 
